<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE Publisher PUBLIC "-//Springer-Verlag//DTD A++ V2.4//EN" "http://devel.springer.de/A++/V2.4/DTD/A++V2.4.dtd">
<Publisher>
  <PublisherInfo>
    <PublisherName>Springer-Verlag</PublisherName>
    <PublisherLocation>New York</PublisherLocation>
  </PublisherInfo>
  <Journal>
    <JournalInfo JournalProductType="ArchiveJournal" NumberingStyle="Unnumbered">
      <JournalID>12248</JournalID>
      <JournalElectronicISSN>1550-7416</JournalElectronicISSN>
      <JournalTitle>The AAPS Journal</JournalTitle>
      <JournalAbbreviatedTitle>AAPS J</JournalAbbreviatedTitle>
      <JournalSubjectGroup>
        <JournalSubject Code="F" Type="Primary">Pharmacy</JournalSubject>
        <JournalSubject Code="F00008" Priority="1" Type="Secondary">Pharmacy</JournalSubject>
        <JournalSubject Code="B21007" Priority="2" Type="Secondary">Pharmacology/Toxicology</JournalSubject>
        <JournalSubject Code="C12002" Priority="3" Type="Secondary">Biotechnology</JournalSubject>
      </JournalSubjectGroup>
    </JournalInfo>
    <Volume>
      <VolumeInfo TocLevels="0" VolumeType="Regular">
        <VolumeIDStart>7</VolumeIDStart>
        <VolumeIDEnd>7</VolumeIDEnd>
        <VolumeIssueCount>4</VolumeIssueCount>
      </VolumeInfo>
      <Issue IssueType="Regular">
        <IssueInfo TocLevels="0">
          <IssueIDStart>1</IssueIDStart>
          <IssueIDEnd>1</IssueIDEnd>
          <IssueArticleCount>25</IssueArticleCount>
          <IssueHistory>
            <CoverDate>
              <Year>2005</Year>
              <Month>3</Month>
            </CoverDate>
          </IssueHistory>
          <IssueCopyright>
            <CopyrightHolderName>American Association of Pharmaceutical Scientists</CopyrightHolderName>
            <CopyrightYear>2005</CopyrightYear>
          </IssueCopyright>
        </IssueInfo>
        <Article ID="Art19">
          <ArticleInfo ArticleType="OriginalPaper" ContainsESM="No" Language="En" NumberingStyle="Unnumbered" TocLevels="0">
            <ArticleID>71201</ArticleID>
            <ArticleDOI>10.1208/aapsj070119</ArticleDOI>
            <ArticleSequenceNumber>19</ArticleSequenceNumber>
            <ArticleTitle Language="En">Introduction of unsaturation into the<Emphasis Type="Italic">N-n</Emphasis>-alkyl chain of the nicotinic receptor antagonists, NONI and NDNI: Effect on affinity and selectivity</ArticleTitle>
            <ArticleFirstPage>E201</ArticleFirstPage>
            <ArticleLastPage>E217</ArticleLastPage>
            <ArticleHistory>
              <RegistrationDate>
                <Year>2008</Year>
                <Month>1</Month>
                <Day>28</Day>
              </RegistrationDate>
              <Received>
                <Year>2005</Year>
                <Month>3</Month>
                <Day>7</Day>
              </Received>
              <Accepted>
                <Year>2005</Year>
                <Month>3</Month>
                <Day>9</Day>
              </Accepted>
            </ArticleHistory>
            <ArticleCopyright>
              <CopyrightHolderName>American Association of Pharmaceutical Scientists</CopyrightHolderName>
              <CopyrightYear>2005</CopyrightYear>
            </ArticleCopyright>
            <ArticleGrants Type="Regular">
              <MetadataGrant Grant="OpenAccess"/>
              <AbstractGrant Grant="OpenAccess"/>
              <BodyPDFGrant Grant="Restricted"/>
              <BodyHTMLGrant Grant="Restricted"/>
              <BibliographyGrant Grant="Restricted"/>
              <ESMGrant Grant="Restricted"/>
            </ArticleGrants>
            <ArticleContext>
              <JournalID>12248</JournalID>
              <VolumeIDStart>7</VolumeIDStart>
              <VolumeIDEnd>7</VolumeIDEnd>
              <IssueIDStart>1</IssueIDStart>
              <IssueIDEnd>1</IssueIDEnd>
            </ArticleContext>
          </ArticleInfo>
          <ArticleHeader>
            <AuthorGroup>
              <Author AffiliationIDS="Aff1">
                <AuthorName DisplayOrder="Western">
                  <GivenName>Sangeetha</GivenName>
                  <GivenName>P.</GivenName>
                  <FamilyName>Sumithran</FamilyName>
                </AuthorName>
              </Author>
              <Author AffiliationIDS="Aff1">
                <AuthorName DisplayOrder="Western">
                  <GivenName>Peter</GivenName>
                  <GivenName>A.</GivenName>
                  <FamilyName>Crooks</FamilyName>
                </AuthorName>
              </Author>
              <Author AffiliationIDS="Aff1" PresentAffiliationID="Aff2">
                <AuthorName DisplayOrder="Western">
                  <GivenName>Rui</GivenName>
                  <FamilyName>Xu</FamilyName>
                </AuthorName>
              </Author>
              <Author AffiliationIDS="Aff1">
                <AuthorName DisplayOrder="Western">
                  <GivenName>Jun</GivenName>
                  <FamilyName>Zhu</FamilyName>
                </AuthorName>
              </Author>
              <Author AffiliationIDS="Aff1">
                <AuthorName DisplayOrder="Western">
                  <GivenName>Agripina</GivenName>
                  <GivenName>G.</GivenName>
                  <FamilyName>Deaciuc</FamilyName>
                </AuthorName>
              </Author>
              <Author AffiliationIDS="Aff1" PresentAffiliationID="Aff3">
                <AuthorName DisplayOrder="Western">
                  <GivenName>Lincoln</GivenName>
                  <GivenName>H.</GivenName>
                  <FamilyName>Wilkins</FamilyName>
                </AuthorName>
              </Author>
              <Author AffiliationIDS="Aff1" CorrespondingAffiliationID="Aff1">
                <AuthorName DisplayOrder="Western">
                  <GivenName>Linda</GivenName>
                  <GivenName>P.</GivenName>
                  <FamilyName>Dwoskin</FamilyName>
                </AuthorName>
                <Contact>
                  <Phone>(859) 257-4743</Phone>
                  <Fax>(859) 257-7564</Fax>
                  <Email>ldwoskin@email.uky.edu</Email>
                </Contact>
              </Author>
              <Affiliation ID="Aff1">
                <OrgDivision>College of Pharmacy</OrgDivision>
                <OrgName>University of Kentucky</OrgName>
                <OrgAddress>
                  <Postcode>40536-0082</Postcode>
                  <City>Lexington</City>
                  <State>KY</State>
                </OrgAddress>
              </Affiliation>
              <Affiliation ID="Aff2">
                <OrgName>Array BioPharma</OrgName>
                <OrgAddress>
                  <Postcode>80301</Postcode>
                  <City>Boulder</City>
                  <State>CO</State>
                </OrgAddress>
              </Affiliation>
              <Affiliation ID="Aff3">
                <OrgName>Bristol-Myers Squibb</OrgName>
                <OrgAddress>
                  <Postcode>70433</Postcode>
                  <City>New Orleans</City>
                  <State>LA</State>
                </OrgAddress>
              </Affiliation>
            </AuthorGroup>
            <Abstract ID="Abs1" Language="En">
              <Heading>Abstract</Heading>
              <Para>
                <Emphasis Type="Italic">N-n</Emphasis>-Octylnicotinium iodide (NONI) and<Emphasis Type="Italic">N-n</Emphasis>-decylnicotinium iodide (NDNI) are selective nicotinic receptor (nAChR) antagonists mediating nicotine-evoked striatal dopamine (DA) release, and inhibiting [<Superscript>3</Superscript>H]nicotine binding, respectively. This study evaluated effects of introducing unsaturation into the<Emphasis Type="Italic">N-n</Emphasis>-alkyl chains of NONI and NDNI on inhibition of [<Superscript>3</Superscript>H]nicotine and [<Superscript>3</Superscript>H]methyllycaconitine binding (α4β2* and α7* nAChRs, respectively),<Superscript>86</Superscript>Rb<Superscript>+</Superscript> efflux and [<Superscript>3</Superscript>H]DA release (agonist or antagonist effects at α4β2* and α6β2*-containing nAChRs, respectively). In the NONI series, introduction of a C<Subscript>3</Subscript>-<Emphasis Type="Italic">cis</Emphasis>-(NONB3c), C<Subscript>3</Subscript>-<Emphasis Type="Italic">trans</Emphasis>-(NONB3t), C<Subscript>7</Subscript>-double-bond (NONB7e), or C<Subscript>3</Subscript>-triple-bond (NONB3y) afforded a 4-fold to 250-fold increased affinity for [<Superscript>3</Superscript>H]nicotine binding sites compared with NONI. NONB7e and NONB3y inhibited nicotine-evoked<Superscript>86</Superscript>Rb<Superscript>+</Superscript> efflux, indicating α4β2* antagonism. NONI analogs exhibited a 3-fold to 8-fold greater potency inhibiting nicotine-evoked [<Superscript>3</Superscript>H]DA overflow compared with NONI (IC<Subscript>50</Subscript>=0.62 μM; Imax=89%), with no change in Imax, except for NONB3y (Imax=50%). In the NDNI series, introduction of a C<Subscript>4</Subscript>-<Emphasis Type="Italic">cis</Emphasis>-(NDNB4c), C<Subscript>4</Subscript>-<Emphasis Type="Italic">trans</Emphasis>-double-bond (NDNB4t), or C<Subscript>3</Subscript>-triple-bond (NDNB3y) afforded a 4-fold to 80-fold decreased affinity for [<Superscript>3</Superscript>H]nicotine binding sites compared with NDNI, whereas introduction of a C<Subscript>9</Subscript>-double-bond (NDNB9e) did not alter affinity. NDNB3y and NDNB4t inhibited nicotine-evoked<Superscript>86</Superscript>Rb<Superscript>+</Superscript> efflux, indicating anatogonism at α4β2* nAChRs. Although NDNI had no effect, NDNB4t and NDNB9e potently inhibited nicotine-evoked [<Superscript>3</Superscript>H]DA overflow (IC<Subscript>50</Subscript>=0.02–0.14μM, Imax=90%), as did NDNB4c (IC<Subscript>50</Subscript>=0.08 μM; Imax=50%), whereas NDNB3y showed no inhibition. None of the analogs had significant affinity for α7* nAChRs. Thus, unsaturated NONI analogs had enhanced affinity at α4β2*-and α6β2*-containing nAChRs, however a general reduction of affinity at α4β2* and an uncovering of antagonist effects at α6β2*-containing nAChRs were observed with unsaturated NDNI analogs.</Para>
            </Abstract>
            <KeywordGroup Language="En">
              <Heading>Keywords</Heading>
              <Keyword>Dopamine release</Keyword>
              <Keyword>dopamine transporter</Keyword>
              <Keyword>drug discovery</Keyword>
              <Keyword>nicotinic receptor antagonist</Keyword>
              <Keyword>nicotine</Keyword>
            </KeywordGroup>
            <AbbreviationGroup>
              <Heading>Abbreviations</Heading>
              <DefinitionList>
                <DefinitionListEntry>
                  <Term>ANOVA</Term>
                  <Description>
                    <Para>analysis of variance</Para>
                  </Description>
                </DefinitionListEntry>
                <DefinitionListEntry>
                  <Term>BSA</Term>
                  <Description>
                    <Para>bovine serum albumin</Para>
                  </Description>
                </DefinitionListEntry>
                <DefinitionListEntry>
                  <Term>DA</Term>
                  <Description>
                    <Para>dopamine</Para>
                  </Description>
                </DefinitionListEntry>
                <DefinitionListEntry>
                  <Term>DAT</Term>
                  <Description>
                    <Para>dopamine transporter</Para>
                  </Description>
                </DefinitionListEntry>
                <DefinitionListEntry>
                  <Term>HEPES</Term>
                  <Description>
                    <Para>N-[2-hydroxyethyl] piperazine-N'-[2-ethanesulfonic acid]</Para>
                  </Description>
                </DefinitionListEntry>
                <DefinitionListEntry>
                  <Term>MLA</Term>
                  <Description>
                    <Para>methyllycaconitine</Para>
                  </Description>
                </DefinitionListEntry>
                <DefinitionListEntry>
                  <Term>nAChR</Term>
                  <Description>
                    <Para>neuronal nicotinic acetylcholine receptor</Para>
                  </Description>
                </DefinitionListEntry>
                <DefinitionListEntry>
                  <Term>NDNI</Term>
                  <Description>
                    <Para>
                      <Emphasis Type="Italic">N-n</Emphasis>-decylnicotinium iodide</Para>
                  </Description>
                </DefinitionListEntry>
                <DefinitionListEntry>
                  <Term>NDNB4c</Term>
                  <Description>
                    <Para>
                      <Emphasis Type="Italic">N-cis-n</Emphasis>-dec-4-enyl nicotinium bromide</Para>
                  </Description>
                </DefinitionListEntry>
                <DefinitionListEntry>
                  <Term>NDNB4t</Term>
                  <Description>
                    <Para>
                      <Emphasis Type="Italic">N-trans-n</Emphasis>-dec-4-enylnicotinium bromide</Para>
                  </Description>
                </DefinitionListEntry>
                <DefinitionListEntry>
                  <Term>NDNB9e</Term>
                  <Description>
                    <Para>
                      <Emphasis Type="Italic">N-n</Emphasis>-dec-9-enylnicotinium bromide</Para>
                  </Description>
                </DefinitionListEntry>
                <DefinitionListEntry>
                  <Term>NDNB3y</Term>
                  <Description>
                    <Para>
                      <Emphasis Type="Italic">N-n</Emphasis>-dec-3-ynylnicotinium bromide</Para>
                  </Description>
                </DefinitionListEntry>
                <DefinitionListEntry>
                  <Term>NONB3c</Term>
                  <Description>
                    <Para>
                      <Emphasis Type="Italic">N-cis-n</Emphasis>-oct-3-enylnicotinium bromide</Para>
                  </Description>
                </DefinitionListEntry>
                <DefinitionListEntry>
                  <Term>NONB3t</Term>
                  <Description>
                    <Para>
                      <Emphasis Type="Italic">N-trans-n</Emphasis>-oct-3-enylnicotinium bromide</Para>
                  </Description>
                </DefinitionListEntry>
                <DefinitionListEntry>
                  <Term>NONB7e</Term>
                  <Description>
                    <Para>
                      <Emphasis Type="Italic">N-n</Emphasis>-oct-7-enylnicotinium bromide</Para>
                  </Description>
                </DefinitionListEntry>
                <DefinitionListEntry>
                  <Term>NONB3y</Term>
                  <Description>
                    <Para>
                      <Emphasis Type="Italic">N-n</Emphasis>-oct-3-ynylnicotinium bromide</Para>
                  </Description>
                </DefinitionListEntry>
                <DefinitionListEntry>
                  <Term>NONI</Term>
                  <Description>
                    <Para>
                      <Emphasis Type="Italic">N-n</Emphasis>-octylnicotinium iodide</Para>
                  </Description>
                </DefinitionListEntry>
                <DefinitionListEntry>
                  <Term>PEI</Term>
                  <Description>
                    <Para>polyethylenimine</Para>
                  </Description>
                </DefinitionListEntry>
                <DefinitionListEntry>
                  <Term>S.E.M.</Term>
                  <Description>
                    <Para>standard error of the mean; * indicates putative nAChR subtype assignment</Para>
                  </Description>
                </DefinitionListEntry>
              </DefinitionList>
            </AbbreviationGroup>
            <ArticleNote Type="Misc">
              <SimplePara>Published: August 29, 2005.</SimplePara>
            </ArticleNote>
          </ArticleHeader>
          <BodyRef FileRef="BodyRef/PDF/12248_2008_Article_71201.pdf" TargetType="OnlinePDF"/>
          <ArticleBackmatter>
            <Bibliography ID="Bib1">
              <Heading>References</Heading>
              <Citation ID="CR1">
                <CitationNumber>1.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>PB</Initials>
                    <FamilyName>Clarke</FamilyName>
                  </BibAuthorName>
                  <Year>1987</Year>
                  <ArticleTitle Language="En">Nicotine and smoking: a perspective from animal studies</ArticleTitle>
                  <JournalTitle>Psychopharmacology (Berl).</JournalTitle>
                  <VolumeID>92</VolumeID>
                  <FirstPage>135</FirstPage>
                  <LastPage>143</LastPage>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaL2sXktlCgtLc%3D</Handle>
                  </Occurrence>
<Occurrence Type="DOI">
<Handle>10.1007/BF00177905</Handle>
</Occurrence>
                </BibArticle>
                <BibUnstructured>Clarke PB. Nicotine and smoking: a perspective from animal studies.<Emphasis Type="Italic">Psychopharmacology (Berl).</Emphasis> 1987;92:135–143.</BibUnstructured>
              </Citation>
              <Citation ID="CR2">
                <CitationNumber>2.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>CS</Initials>
                    <FamilyName>Pomerleau</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>OF</Initials>
                    <FamilyName>Pomerleau</FamilyName>
                  </BibAuthorName>
                  <Year>1992</Year>
                  <ArticleTitle Language="En">Euphoriant effects of nicotine in smokers. Euphoriant effects of nicotine in smokers</ArticleTitle>
                  <JournalTitle>Psychopharmacology (Berl).</JournalTitle>
                  <VolumeID>108</VolumeID>
                  <FirstPage>460</FirstPage>
                  <LastPage>465</LastPage>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK38Xmt1yhtbs%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Pomerleau CS, Pomerleau OF. Euphoriant effects of nicotine in smokers. Euphoriant effects of nicotine in smokers.<Emphasis Type="Italic">Psychopharmacology (Berl).</Emphasis> 1992;108:460–465.</BibUnstructured>
              </Citation>
              <Citation ID="CR3">
                <CitationNumber>3.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>DJ</Initials>
                    <FamilyName>Balfour</FamilyName>
                  </BibAuthorName>
                  <Year>2002</Year>
                  <ArticleTitle Language="En">The neurobiology of tobacco dependence: a commentary</ArticleTitle>
                  <JournalTitle>Respiration</JournalTitle>
                  <VolumeID>69</VolumeID>
                  <FirstPage>7</FirstPage>
                  <LastPage>11</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11844955</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD38XhtFOqsrY%3D</Handle>
                  </Occurrence>
<Occurrence Type="DOI">
<Handle>10.1159/000049362</Handle>
</Occurrence>
                </BibArticle>
                <BibUnstructured>Balfour DJ. The neurobiology of tobacco dependence: a commentary.<Emphasis Type="Italic">Respiration</Emphasis>. 2002;69:7–11.</BibUnstructured>
              </Citation>
              <Citation ID="CR4">
                <CitationNumber>4.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>GF</Initials>
                    <FamilyName>Koob</FamilyName>
                  </BibAuthorName>
                  <Year>1992</Year>
                  <ArticleTitle Language="En">Neural mechanisms of drug reinforcement</ArticleTitle>
                  <JournalTitle>Ann N Y Acad Sci.</JournalTitle>
                  <VolumeID>654</VolumeID>
                  <FirstPage>171</FirstPage>
                  <LastPage>191</LastPage>
                  <Occurrence Type="PID">
                    <Handle>1632582</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK38XlvVCisbo%3D</Handle>
                  </Occurrence>
<Occurrence Type="DOI">
<Handle>10.1111/j.1749-6632.1992.tb25966.x</Handle>
</Occurrence>
                </BibArticle>
                <BibUnstructured>Koob GF. Neural mechanisms of drug reinforcement.<Emphasis Type="Italic">Ann N Y Acad Sci.</Emphasis> 1992;654:171–191.</BibUnstructured>
              </Citation>
              <Citation ID="CR5">
                <CitationNumber>5.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>WA</Initials>
                    <FamilyName>Corrigall</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>KBJ</Initials>
                    <FamilyName>Franklin</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>KM</Initials>
                    <FamilyName>Coen</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>PBS</Initials>
                    <FamilyName>Clarke</FamilyName>
                  </BibAuthorName>
                  <Year>1992</Year>
                  <ArticleTitle Language="En">The mesolimbic dopaminergic system is implicated in the reinforcing effects of nicotine</ArticleTitle>
                  <JournalTitle>Psychopharmacology (Berl).</JournalTitle>
                  <VolumeID>107</VolumeID>
                  <FirstPage>285</FirstPage>
                  <LastPage>289</LastPage>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK38XktVamu7c%3D</Handle>
                  </Occurrence>
<Occurrence Type="DOI">
<Handle>10.1007/BF02245149</Handle>
</Occurrence>
                </BibArticle>
                <BibUnstructured>Corrigall WA, Franklin KBJ, Coen KM, Clarke PBS. The mesolimbic dopaminergic system is implicated in the reinforcing effects of nicotine.<Emphasis Type="Italic">Psychopharmacology (Berl).</Emphasis> 1992;107:285–289.</BibUnstructured>
              </Citation>
              <Citation ID="CR6">
                <CitationNumber>6.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>IP</Initials>
                    <FamilyName>Stolerman</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>MJ</Initials>
                    <FamilyName>Jarvis</FamilyName>
                  </BibAuthorName>
                  <Year>1995</Year>
                  <ArticleTitle Language="En">The scientific case that nicotine is addictive</ArticleTitle>
                  <JournalTitle>Psychopharmacology (Berl).</JournalTitle>
                  <VolumeID>117</VolumeID>
                  <FirstPage>2</FirstPage>
                  <LastPage>10</LastPage>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK2MXkslSisrw%3D</Handle>
                  </Occurrence>
<Occurrence Type="DOI">
<Handle>10.1007/BF02245088</Handle>
</Occurrence>
                </BibArticle>
                <BibUnstructured>Stolerman IP, Jarvis MJ. The scientific case that nicotine is addictive.<Emphasis Type="Italic">Psychopharmacology (Berl).</Emphasis> 1995;117:2–10.</BibUnstructured>
              </Citation>
              <Citation ID="CR7">
                <CitationNumber>7.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>F</Initials>
                    <FamilyName>Pontieri</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>G</Initials>
                    <FamilyName>Tanda</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>F</Initials>
                    <FamilyName>Orgi</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>G</Initials>
                    <FamilyName>DiChiara</FamilyName>
                  </BibAuthorName>
                  <Year>1996</Year>
                  <ArticleTitle Language="En">Effects of nicotine on the nucleus accumbens and similarity to those of addictive drugs</ArticleTitle>
                  <JournalTitle>Nature</JournalTitle>
                  <VolumeID>382</VolumeID>
                  <FirstPage>255</FirstPage>
                  <LastPage>257</LastPage>
                  <Occurrence Type="PID">
                    <Handle>8717040</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK28XksVWhur8%3D</Handle>
                  </Occurrence>
<Occurrence Type="DOI">
<Handle>10.1038/382255a0</Handle>
</Occurrence>
                </BibArticle>
                <BibUnstructured>Pontieri F, Tanda G, Orgi F, DiChiara G. Effects of nicotine on the nucleus accumbens and similarity to those of addictive drugs.<Emphasis Type="Italic">Nature</Emphasis>. 1996;382:255–257.</BibUnstructured>
              </Citation>
              <Citation ID="CR8">
                <CitationNumber>8.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>R</Initials>
                    <FamilyName>Spanagel</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>F</Initials>
                    <FamilyName>Weiss</FamilyName>
                  </BibAuthorName>
                  <Year>1999</Year>
                  <ArticleTitle Language="En">The dopamine hypothesis of reward: past and current status</ArticleTitle>
                  <JournalTitle>Trands Neurosci.</JournalTitle>
                  <VolumeID>22</VolumeID>
                  <FirstPage>521</FirstPage>
                  <LastPage>527</LastPage>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK1MXmvVKhtrg%3D</Handle>
                  </Occurrence>
<Occurrence Type="DOI">
<Handle>10.1016/S0166-2236(99)01447-2</Handle>
</Occurrence>
                </BibArticle>
                <BibUnstructured>Spanagel R, Weiss F. The dopamine hypothesis of reward: past and current status.<Emphasis Type="Italic">Trands Neurosci.</Emphasis> 1999;22:521–527.</BibUnstructured>
              </Citation>
              <Citation ID="CR9">
                <CitationNumber>9.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>G</Initials>
                    <FamilyName>Chiara</FamilyName>
                    <Particle>Di</Particle>
                  </BibAuthorName>
                  <Year>2000</Year>
                  <ArticleTitle Language="En">Role of dopamine in the behavioural actions of nicotine related to addiction</ArticleTitle>
                  <JournalTitle>Eur J Pharmacol.</JournalTitle>
                  <VolumeID>393</VolumeID>
                  <FirstPage>295</FirstPage>
                  <LastPage>314</LastPage>
                  <Occurrence Type="PID">
                    <Handle>10771025</Handle>
                  </Occurrence>
<Occurrence Type="DOI">
<Handle>10.1016/S0014-2999(00)00122-9</Handle>
</Occurrence>
                </BibArticle>
                <BibUnstructured>Di Chiara G. Role of dopamine in the behavioural actions of nicotine related to addiction.<Emphasis Type="Italic">Eur J Pharmacol.</Emphasis> 2000;393:295–314.</BibUnstructured>
              </Citation>
              <Citation ID="CR10">
                <CitationNumber>10.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>RA</Initials>
                    <FamilyName>Wise</FamilyName>
                  </BibAuthorName>
                  <Year>2000</Year>
                  <ArticleTitle Language="En">Addiction becomes a brain disease</ArticleTitle>
                  <JournalTitle>Neuron</JournalTitle>
                  <VolumeID>26</VolumeID>
                  <FirstPage>27</FirstPage>
                  <LastPage>33</LastPage>
                  <Occurrence Type="PID">
                    <Handle>10798389</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3cXjtFSksbc%3D</Handle>
                  </Occurrence>
<Occurrence Type="DOI">
<Handle>10.1016/S0896-6273(00)81134-4</Handle>
</Occurrence>
                </BibArticle>
                <BibUnstructured>Wise RA. Addiction becomes a brain disease.<Emphasis Type="Italic">Neuron</Emphasis>. 2000;26:27–33.</BibUnstructured>
              </Citation>
              <Citation ID="CR11">
                <CitationNumber>11.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>RA</Initials>
                    <FamilyName>Wise</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>MA</Initials>
                    <FamilyName>Bozarth</FamilyName>
                  </BibAuthorName>
                  <Year>1987</Year>
                  <ArticleTitle Language="En">A psychomotor stimulant theory of addiction</ArticleTitle>
                  <JournalTitle>Psychol Rev.</JournalTitle>
                  <VolumeID>94</VolumeID>
                  <FirstPage>469</FirstPage>
                  <LastPage>492</LastPage>
                  <Occurrence Type="PID">
                    <Handle>3317472</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:STN:280:DyaL1c%2FmvFShtg%3D%3D</Handle>
                  </Occurrence>
<Occurrence Type="DOI">
<Handle>10.1037/0033-295X.94.4.469</Handle>
</Occurrence>
                </BibArticle>
                <BibUnstructured>Wise RA, Bozarth MA. A psychomotor stimulant theory of addiction.<Emphasis Type="Italic">Psychol Rev.</Emphasis> 1987;94:469–492.</BibUnstructured>
              </Citation>
              <Citation ID="CR12">
                <CitationNumber>12.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>MT</Initials>
                    <FamilyName>Bardo</FamilyName>
                  </BibAuthorName>
                  <Year>1998</Year>
                  <ArticleTitle Language="En">Neuropharmacological mechanisms of drug reward: beyond dopamine in the nucleus accumbens</ArticleTitle>
                  <JournalTitle>Crit Rev Neurobiol.</JournalTitle>
                  <VolumeID>12</VolumeID>
                  <FirstPage>37</FirstPage>
                  <LastPage>67</LastPage>
                  <Occurrence Type="PID">
                    <Handle>9444481</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK1cXjslKmug%3D%3D</Handle>
                  </Occurrence>
<Occurrence Type="DOI">
<Handle>10.1615/CritRevNeurobiol.v12.i1-2.30</Handle>
</Occurrence>
                </BibArticle>
                <BibUnstructured>Bardo MT. Neuropharmacological mechanisms of drug reward: beyond dopamine in the nucleus accumbens.<Emphasis Type="Italic">Crit Rev Neurobiol.</Emphasis> 1998;12:37–67.</BibUnstructured>
              </Citation>
              <Citation ID="CR13">
                <CitationNumber>13.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>GF</Initials>
                    <FamilyName>Koob</FamilyName>
                  </BibAuthorName>
                  <Year>1999</Year>
                  <ArticleTitle Language="En">The role of the striatopallidal and extended amygdala systems in drug addiction</ArticleTitle>
                  <JournalTitle>Ann N Y Acad Sci.</JournalTitle>
                  <VolumeID>877</VolumeID>
                  <FirstPage>445</FirstPage>
                  <LastPage>460</LastPage>
                  <Occurrence Type="PID">
                    <Handle>10415664</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK1MXkslGmtLY%3D</Handle>
                  </Occurrence>
<Occurrence Type="DOI">
<Handle>10.1111/j.1749-6632.1999.tb09282.x</Handle>
</Occurrence>
                </BibArticle>
                <BibUnstructured>Koob GF. The role of the striatopallidal and extended amygdala systems in drug addiction.<Emphasis Type="Italic">Ann N Y Acad Sci.</Emphasis> 1999;877:445–460.</BibUnstructured>
              </Citation>
              <Citation ID="CR14">
                <CitationNumber>14.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>G</Initials>
                    <FamilyName>Chiara</FamilyName>
                    <Particle>Di</Particle>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>V</Initials>
                    <FamilyName>Bassareo</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Fenu</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2004</Year>
                  <ArticleTitle Language="En">Dopamine and drug addiction: the nucleus accumbens shell connection</ArticleTitle>
                  <JournalTitle>Neuropharmacology</JournalTitle>
                  <VolumeID>47</VolumeID>
                  <FirstPage>227</FirstPage>
                  <LastPage>241</LastPage>
                  <Occurrence Type="PID">
                    <Handle>15464140</Handle>
                  </Occurrence>
<Occurrence Type="DOI">
<Handle>10.1016/j.neuropharm.2004.06.032</Handle>
</Occurrence>
                </BibArticle>
                <BibUnstructured>Di Chiara G, Bassareo V, Fenu S, et al. Dopamine and drug addiction: the nucleus accumbens shell connection.<Emphasis Type="Italic">Neuropharmacology</Emphasis>. 2004;47:227–241.</BibUnstructured>
              </Citation>
              <Citation ID="CR15">
                <CitationNumber>15.</CitationNumber>
                <BibChapter>
                  <BibAuthorName>
                    <Initials>HC</Initials>
                    <FamilyName>Fibiger</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>AG</Initials>
                    <FamilyName>Phillips</FamilyName>
                  </BibAuthorName>
                  <Year>1987</Year>
                  <ChapterTitle Language="En">Role of catecholamine transmitters in brain reward systems</ChapterTitle>
                  <BibEditorName>
                    <Initials>J</Initials>
                    <FamilyName>Engel</FamilyName>
                  </BibEditorName>
                  <BibEditorName>
                    <Initials>L</Initials>
                    <FamilyName>Oreland</FamilyName>
                  </BibEditorName>
                  <Eds/>
                  <BookTitle>Brain Reward Systems and Abuse</BookTitle>
                  <PublisherName>Raven Press</PublisherName>
                  <PublisherLocation>New York, NY</PublisherLocation>
                  <FirstPage>61</FirstPage>
                  <LastPage>74</LastPage>
                </BibChapter>
                <BibUnstructured>Fibiger HC, Phillips AG. Role of catecholamine transmitters in brain reward systems. In: Engel J, Oreland L, eds.<Emphasis Type="Italic">Brain Reward Systems and Abuse</Emphasis>. New York, NY: Raven Press; 1987:61–74.</BibUnstructured>
              </Citation>
              <Citation ID="CR16">
                <CitationNumber>16.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>HD</Initials>
                    <FamilyName>Mansvelder</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>DS</Initials>
                    <FamilyName>McGehee</FamilyName>
                  </BibAuthorName>
                  <Year>2002</Year>
                  <ArticleTitle Language="En">Cellular and synaptic mechanisms of nicotine addiction</ArticleTitle>
                  <JournalTitle>J Neurobiol</JournalTitle>
                  <VolumeID>53</VolumeID>
                  <FirstPage>606</FirstPage>
                  <LastPage>617</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12436424</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD38Xps1KlsbY%3D</Handle>
                  </Occurrence>
<Occurrence Type="DOI">
<Handle>10.1002/neu.10148</Handle>
</Occurrence>
                </BibArticle>
                <BibUnstructured>Mansvelder HD, McGehee DS. Cellular and synaptic mechanisms of nicotine addiction.<Emphasis Type="Italic">J Neurobiol</Emphasis>. 2002;53:606–617.</BibUnstructured>
              </Citation>
              <Citation ID="CR17">
                <CitationNumber>17.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>AM</Initials>
                    <FamilyName>Mathieu-Kia</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>SH</Initials>
                    <FamilyName>Kellog</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>ER</Initials>
                    <FamilyName>Butelman</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>MJ</Initials>
                    <FamilyName>Kreek</FamilyName>
                  </BibAuthorName>
                  <Year>2002</Year>
                  <ArticleTitle Language="En">Nicotine addiction: insights from recent animal studies</ArticleTitle>
                  <JournalTitle>Psychopharmacology (Berl)</JournalTitle>
                  <VolumeID>162</VolumeID>
                  <FirstPage>102</FirstPage>
                  <LastPage>118</LastPage>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD38Xmtlert7s%3D</Handle>
                  </Occurrence>
<Occurrence Type="DOI">
<Handle>10.1007/s00213-002-1096-0</Handle>
</Occurrence>
                </BibArticle>
                <BibUnstructured>Mathieu-Kia AM, Kellog SH, Butelman ER, Kreek MJ. Nicotine addiction: insights from recent animal studies.<Emphasis Type="Italic">Psychopharmacology (Berl)</Emphasis>. 2002;162:102–118.</BibUnstructured>
              </Citation>
              <Citation ID="CR18">
                <CitationNumber>18.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>KC</Initials>
                    <FamilyName>Berridge</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>TE</Initials>
                    <FamilyName>Robinson</FamilyName>
                  </BibAuthorName>
                  <Year>1998</Year>
                  <ArticleTitle Language="En">What is the role of dopamine in reward: hedonic impact, reward learning, or incentive salience?</ArticleTitle>
                  <JournalTitle>Brain Res Brain Res Rev.</JournalTitle>
                  <VolumeID>28</VolumeID>
                  <FirstPage>309</FirstPage>
                  <LastPage>369</LastPage>
                  <Occurrence Type="PID">
                    <Handle>9858756</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK1cXotVKhsrY%3D</Handle>
                  </Occurrence>
<Occurrence Type="DOI">
<Handle>10.1016/S0165-0173(98)00019-8</Handle>
</Occurrence>
                </BibArticle>
                <BibUnstructured>Berridge KC, Robinson TE. What is the role of dopamine in reward: hedonic impact, reward learning, or incentive salience?.<Emphasis Type="Italic">Brain Res Brain Res Rev.</Emphasis> 1998;28:309–369.</BibUnstructured>
              </Citation>
              <Citation ID="CR19">
                <CitationNumber>19.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>K</Initials>
                    <FamilyName>Shima</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J</Initials>
                    <FamilyName>Tanji</FamilyName>
                  </BibAuthorName>
                  <Year>1998</Year>
                  <ArticleTitle Language="En">Role for cingulate motor area cells in voluntary movement selection based on reward</ArticleTitle>
                  <JournalTitle>Science.</JournalTitle>
                  <VolumeID>282</VolumeID>
                  <FirstPage>1335</FirstPage>
                  <LastPage>1338</LastPage>
                  <Occurrence Type="PID">
                    <Handle>9812901</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK1cXnsFCisrg%3D</Handle>
                  </Occurrence>
<Occurrence Type="DOI">
<Handle>10.1126/science.282.5392.1335</Handle>
</Occurrence>
                </BibArticle>
                <BibUnstructured>Shima K, Tanji J. Role for cingulate motor area cells in voluntary movement selection based on reward.<Emphasis Type="Italic">Science.</Emphasis> 1998;282:1335–1338.</BibUnstructured>
              </Citation>
              <Citation ID="CR20">
                <CitationNumber>20.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>JE</Initials>
                    <FamilyName>Rose</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>FM</Initials>
                    <FamilyName>Behm</FamilyName>
                  </BibAuthorName>
                  <Year>2004</Year>
                  <ArticleTitle Language="En">Extinguishing the rewarding value of smoke cues: pharmacological and behavioral treatments</ArticleTitle>
                  <JournalTitle>Nicotine Tob Res.</JournalTitle>
                  <VolumeID>6</VolumeID>
                  <FirstPage>523</FirstPage>
                  <LastPage>532</LastPage>
                  <Occurrence Type="PID">
                    <Handle>15203786</Handle>
                  </Occurrence>
<Occurrence Type="DOI">
<Handle>10.1080/14622200410001696501</Handle>
</Occurrence>
                </BibArticle>
                <BibUnstructured>Rose JE, Behm FM. Extinguishing the rewarding value of smoke cues: pharmacological and behavioral treatments.<Emphasis Type="Italic">Nicotine Tob Res.</Emphasis> 2004;6:523–532.</BibUnstructured>
              </Citation>
              <Citation ID="CR21">
                <CitationNumber>21.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>AL</Initials>
                    <FamilyName>Brody</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>MA</Initials>
                    <FamilyName>Mandelkern</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>G</Initials>
                    <FamilyName>Lee</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2004</Year>
                  <ArticleTitle Language="En">Attenuation of cue-induced cigarette craving and anterior cingulate cortex activation in bupropion-treated smokers: a preliminary study</ArticleTitle>
                  <JournalTitle>Psychiatry Res.</JournalTitle>
                  <VolumeID>130</VolumeID>
                  <FirstPage>269</FirstPage>
                  <LastPage>281</LastPage>
                  <Occurrence Type="PID">
                    <Handle>15135160</Handle>
                  </Occurrence>
<Occurrence Type="DOI">
<Handle>10.1016/j.pscychresns.2003.12.006</Handle>
</Occurrence>
                </BibArticle>
                <BibUnstructured>Brody AL, Mandelkern MA, Lee G, et al. Attenuation of cue-induced cigarette craving and anterior cingulate cortex activation in bupropion-treated smokers: a preliminary study.<Emphasis Type="Italic">Psychiatry Res.</Emphasis> 2004;130:269–281.</BibUnstructured>
              </Citation>
              <Citation ID="CR22">
                <CitationNumber>22.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>C</Initials>
                    <FamilyName>Martin-Soelch</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>KL</Initials>
                    <FamilyName>Leenders</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>AF</Initials>
                    <FamilyName>Chevalley</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2001</Year>
                  <ArticleTitle Language="En">Reward mechanisms in the brain and their role in dependence: evidence from neuro-physiological and neuroimaging studies</ArticleTitle>
                  <JournalTitle>Brain Res Brain Res Rev.</JournalTitle>
                  <VolumeID>36</VolumeID>
                  <FirstPage>139</FirstPage>
                  <LastPage>149</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11690610</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:STN:280:DC%2BD3MnktVCktA%3D%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Martin-Soelch C, Leenders KL, Chevalley AF, et al. Reward mechanisms in the brain and their role in dependence: evidence from neuro-physiological and neuroimaging studies.<Emphasis Type="Italic">Brain Res Brain Res Rev.</Emphasis> 2001;36:139–149.</BibUnstructured>
              </Citation>
              <Citation ID="CR23">
                <CitationNumber>23.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>EA</Initials>
                    <FamilyName>Stein</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J</Initials>
                    <FamilyName>Pankiewicz</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>HH</Initials>
                    <FamilyName>Harsch</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>1998</Year>
                  <ArticleTitle Language="En">Nicotine-induced limbic cortical activation in the human brain: a functional MRI study</ArticleTitle>
                  <JournalTitle>Am J Psychiatry.</JournalTitle>
                  <VolumeID>155</VolumeID>
                  <FirstPage>1009</FirstPage>
                  <LastPage>1015</LastPage>
                  <Occurrence Type="PID">
                    <Handle>9699686</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:STN:280:DyaK1czmtlaltA%3D%3D</Handle>
                  </Occurrence>
<Occurrence Type="DOI">
<Handle>10.1176/ajp.155.8.1009</Handle>
</Occurrence>
                </BibArticle>
                <BibUnstructured>Stein EA, Pankiewicz J, Harsch HH, et al. Nicotine-induced limbic cortical activation in the human brain: a functional MRI study.<Emphasis Type="Italic">Am J Psychiatry.</Emphasis> 1998;155:1009–1015.</BibUnstructured>
              </Citation>
              <Citation ID="CR24">
                <CitationNumber>24.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>SP</Initials>
                    <FamilyName>Barrett</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>I</Initials>
                    <FamilyName>Boileau</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J</Initials>
                    <FamilyName>Okker</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>RO</Initials>
                    <FamilyName>Pihl</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Dagher</FamilyName>
                  </BibAuthorName>
                  <Year>2004</Year>
                  <ArticleTitle Language="En">The hedonic response to cigarette smoking is proportional to dopamine release in the human striatum as measured by positron emission tomography and [<Superscript>11</Superscript>C]raclopride</ArticleTitle>
                  <JournalTitle>Synapse</JournalTitle>
                  <VolumeID>54</VolumeID>
                  <FirstPage>65</FirstPage>
                  <LastPage>71</LastPage>
                  <Occurrence Type="PID">
                    <Handle>15352131</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2cXosV2nsb4%3D</Handle>
                  </Occurrence>
<Occurrence Type="DOI">
<Handle>10.1002/syn.20066</Handle>
</Occurrence>
                </BibArticle>
                <BibUnstructured>Barrett SP, Boileau I, Okker J, Pihl RO, Dagher A. The hedonic response to cigarette smoking is proportional to dopamine release in the human striatum as measured by positron emission tomography and [<Superscript>11</Superscript>C]raclopride.<Emphasis Type="Italic">Synapse</Emphasis>. 2004;54:65–71.</BibUnstructured>
              </Citation>
              <Citation ID="CR25">
                <CitationNumber>25.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>MJ</Initials>
                    <FamilyName>Parker</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Beck</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>CW</Initials>
                    <FamilyName>Luetje</FamilyName>
                  </BibAuthorName>
                  <Year>1998</Year>
                  <ArticleTitle Language="En">Neuronal nicotinic receptor β2 and β4 subunits confer large differences in agonist binding affinity</ArticleTitle>
                  <JournalTitle>Mol Pharmacol</JournalTitle>
                  <VolumeID>54</VolumeID>
                  <FirstPage>1132</FirstPage>
                  <LastPage>1139</LastPage>
                  <Occurrence Type="PID">
                    <Handle>9855644</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK1MXptVei</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Parker MJ, Beck A, Luetje CW. Neuronal nicotinic receptor β2 and β4 subunits confer large differences in agonist binding affinity.<Emphasis Type="Italic">Mol Pharmacol</Emphasis>. 1998;54:1132–1139.</BibUnstructured>
              </Citation>
              <Citation ID="CR26">
                <CitationNumber>26.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>DS</Initials>
                    <FamilyName>McGehee</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>LW</Initials>
                    <FamilyName>Role</FamilyName>
                  </BibAuthorName>
                  <Year>1995</Year>
                  <ArticleTitle Language="En">Physiological diversity of nicotinic acetyl-choline receptors expressed by vertebrate neurons</ArticleTitle>
                  <JournalTitle>Annu Rev Physiol.</JournalTitle>
                  <VolumeID>57</VolumeID>
                  <FirstPage>521</FirstPage>
                  <LastPage>546</LastPage>
                  <Occurrence Type="PID">
                    <Handle>7778876</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK2MXksVeqsLk%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>McGehee DS, Role LW. Physiological diversity of nicotinic acetyl-choline receptors expressed by vertebrate neurons.<Emphasis Type="Italic">Annu Rev Physiol.</Emphasis> 1995;57:521–546.</BibUnstructured>
              </Citation>
              <Citation ID="CR27">
                <CitationNumber>27.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Wonnacott</FamilyName>
                  </BibAuthorName>
                  <Year>1997</Year>
                  <ArticleTitle Language="En">Presynaptic nicotinic ACh receptors</ArticleTitle>
                  <JournalTitle>Trends Neurosci</JournalTitle>
                  <VolumeID>20</VolumeID>
                  <FirstPage>92</FirstPage>
                  <LastPage>98</LastPage>
                  <Occurrence Type="PID">
                    <Handle>9023878</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK2sXhtFajtrk%3D</Handle>
                  </Occurrence>
<Occurrence Type="DOI">
<Handle>10.1016/S0166-2236(96)10073-4</Handle>
</Occurrence>
                </BibArticle>
                <BibUnstructured>Wonnacott S. Presynaptic nicotinic ACh receptors.<Emphasis Type="Italic">Trends Neurosci</Emphasis>. 1997;20:92–98.</BibUnstructured>
              </Citation>
              <Citation ID="CR28">
                <CitationNumber>28.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>CW</Initials>
                    <FamilyName>Luetje</FamilyName>
                  </BibAuthorName>
                  <Year>2004</Year>
                  <ArticleTitle Language="En">Getting past the asterisk: the subunit composition of presynaptic nicotinic receptors that modulate striatal dopamine release</ArticleTitle>
                  <JournalTitle>Mol Pharmacol</JournalTitle>
                  <VolumeID>65</VolumeID>
                  <FirstPage>1333</FirstPage>
                  <LastPage>1335</LastPage>
                  <Occurrence Type="PID">
                    <Handle>15155826</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2cXksFagsbc%3D</Handle>
                  </Occurrence>
<Occurrence Type="DOI">
<Handle>10.1124/mol.65.6.1333</Handle>
</Occurrence>
                </BibArticle>
                <BibUnstructured>Luetje CW. Getting past the asterisk: the subunit composition of presynaptic nicotinic receptors that modulate striatal dopamine release.<Emphasis Type="Italic">Mol Pharmacol</Emphasis>. 2004;65:1333–1335.</BibUnstructured>
              </Citation>
              <Citation ID="CR29">
                <CitationNumber>29.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>C</Initials>
                    <FamilyName>Gotti</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>F</Initials>
                    <FamilyName>Clementi</FamilyName>
                  </BibAuthorName>
                  <Year>2004</Year>
                  <ArticleTitle Language="En">Neuronal nicotinic receptors: from structure to pathology</ArticleTitle>
                  <JournalTitle>Prog Neurobiol</JournalTitle>
                  <VolumeID>74</VolumeID>
                  <FirstPage>363</FirstPage>
                  <LastPage>396</LastPage>
                  <Occurrence Type="PID">
                    <Handle>15649582</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2MXksVertA%3D%3D</Handle>
                  </Occurrence>
<Occurrence Type="DOI">
<Handle>10.1016/j.pneurobio.2004.09.006</Handle>
</Occurrence>
                </BibArticle>
                <BibUnstructured>Gotti C, Clementi F. Neuronal nicotinic receptors: from structure to pathology.<Emphasis Type="Italic">Prog Neurobiol</Emphasis>. 2004;74:363–396.</BibUnstructured>
              </Citation>
              <Citation ID="CR30">
                <CitationNumber>30.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>JE</Initials>
                    <FamilyName>Irvine</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>PS</Initials>
                    <FamilyName>Hendericks</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>TH</Initials>
                    <FamilyName>Brandon</FamilyName>
                  </BibAuthorName>
                  <Year>2003</Year>
                  <ArticleTitle Language="En">The increasing recalcitrance of smokers in clinical trials II: pharmacotherapy trials</ArticleTitle>
                  <JournalTitle>Nicotine Tob Res.</JournalTitle>
                  <VolumeID>5</VolumeID>
                  <FirstPage>27</FirstPage>
                  <LastPage>35</LastPage>
<Occurrence Type="DOI">
<Handle>10.1080/1462220031000070534</Handle>
</Occurrence>
                </BibArticle>
                <BibUnstructured>Irvine JE, Hendericks PS, Brandon TH. The increasing recalcitrance of smokers in clinical trials II: pharmacotherapy trials.<Emphasis Type="Italic">Nicotine Tob Res.</Emphasis> 2003;5:27–35.</BibUnstructured>
              </Citation>
              <Citation ID="CR31">
                <CitationNumber>31.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>RD</Initials>
                    <FamilyName>Hurt</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JE</Initials>
                    <FamilyName>Krook</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>IT</Initials>
                    <FamilyName>Croghan</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2003</Year>
                  <ArticleTitle Language="En">Nicotine patch therapy based on smoking rate followed by bupropion for prevention of relapse to smoking</ArticleTitle>
                  <JournalTitle>J Clin Oncol.</JournalTitle>
                  <VolumeID>21</VolumeID>
                  <FirstPage>914</FirstPage>
                  <LastPage>920</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12610193</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2cXpsVGqs78%3D</Handle>
                  </Occurrence>
<Occurrence Type="DOI">
<Handle>10.1200/JCO.2003.08.160</Handle>
</Occurrence>
                </BibArticle>
                <BibUnstructured>Hurt RD, Krook JE, Croghan IT, et al. Nicotine patch therapy based on smoking rate followed by bupropion for prevention of relapse to smoking.<Emphasis Type="Italic">J Clin Oncol.</Emphasis> 2003;21:914–920.</BibUnstructured>
              </Citation>
              <Citation ID="CR32">
                <CitationNumber>32.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>TP</Initials>
                    <FamilyName>George</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>SS</Initials>
                    <FamilyName>O'Malley</FamilyName>
                  </BibAuthorName>
                  <Year>2004</Year>
                  <ArticleTitle Language="En">Current pharmacological treatments for nicotine dependence</ArticleTitle>
                  <JournalTitle>Trends Pharmacol Sci.</JournalTitle>
                  <VolumeID>25</VolumeID>
                  <FirstPage>42</FirstPage>
                  <LastPage>48</LastPage>
                  <Occurrence Type="PID">
                    <Handle>14723978</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2cXjtFehtw%3D%3D</Handle>
                  </Occurrence>
<Occurrence Type="DOI">
<Handle>10.1016/j.tips.2003.11.003</Handle>
</Occurrence>
                </BibArticle>
                <BibUnstructured>George TP, O'Malley SS. Current pharmacological treatments for nicotine dependence.<Emphasis Type="Italic">Trends Pharmacol Sci.</Emphasis> 2004;25:42–48.</BibUnstructured>
              </Citation>
              <Citation ID="CR33">
                <CitationNumber>33.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>P</Initials>
                    <FamilyName>Wileyto</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>F</Initials>
                    <FamilyName>Patterson</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>R</Initials>
                    <FamilyName>Niaura</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2004</Year>
                  <ArticleTitle Language="En">Do small lapses predict relapse to smoking behavior under bupropion treatment?</ArticleTitle>
                  <JournalTitle>Nicotine Tob Res.</JournalTitle>
                  <VolumeID>6</VolumeID>
                  <FirstPage>357</FirstPage>
                  <LastPage>366</LastPage>
                  <Occurrence Type="PID">
                    <Handle>15203809</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2cXjsVCqsbk%3D</Handle>
                  </Occurrence>
<Occurrence Type="DOI">
<Handle>10.1080/1462220042000202463</Handle>
</Occurrence>
                </BibArticle>
                <BibUnstructured>Wileyto P, Patterson F, Niaura R, et al. Do small lapses predict relapse to smoking behavior under bupropion treatment?.<Emphasis Type="Italic">Nicotine Tob Res.</Emphasis> 2004;6:357–366.</BibUnstructured>
              </Citation>
              <Citation ID="CR34">
                <CitationNumber>34.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>E</Initials>
                    <FamilyName>Richelson</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Pfenning</FamilyName>
                  </BibAuthorName>
                  <Year>1984</Year>
                  <ArticleTitle Language="En">Blockade by antidepressants and related compounds of biogenic amine uptake into rat brain synaptosomes: most antidepressants selectively block norepinephrine uptake</ArticleTitle>
                  <JournalTitle>Eur J Pharmacol</JournalTitle>
                  <VolumeID>104</VolumeID>
                  <FirstPage>277</FirstPage>
                  <LastPage>286</LastPage>
                  <Occurrence Type="PID">
                    <Handle>6499924</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaL2cXlvVeqtL8%3D</Handle>
                  </Occurrence>
<Occurrence Type="DOI">
<Handle>10.1016/0014-2999(84)90403-5</Handle>
</Occurrence>
                </BibArticle>
                <BibUnstructured>Richelson E, Pfenning M. Blockade by antidepressants and related compounds of biogenic amine uptake into rat brain synaptosomes: most antidepressants selectively block norepinephrine uptake.<Emphasis Type="Italic">Eur J Pharmacol</Emphasis>. 1984;104:277–286.</BibUnstructured>
              </Citation>
              <Citation ID="CR35">
                <CitationNumber>35.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>GG</Initials>
                    <FamilyName>Nomikos</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>G</Initials>
                    <FamilyName>Damsma</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>D</Initials>
                    <FamilyName>Wenkstern</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>HC</Initials>
                    <FamilyName>Fibiger</FamilyName>
                  </BibAuthorName>
                  <Year>1989</Year>
                  <ArticleTitle Language="En">Acute effects of bupropion on extracellular dopamine concentrations in rat striatum and nucleus accumbens studied by in vivo microdialysis</ArticleTitle>
                  <JournalTitle>Neuropsychopharmacology.</JournalTitle>
                  <VolumeID>2</VolumeID>
                  <FirstPage>273</FirstPage>
                  <LastPage>279</LastPage>
                  <Occurrence Type="PID">
                    <Handle>2482026</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK3cXptFKrsQ%3D%3D</Handle>
                  </Occurrence>
<Occurrence Type="DOI">
<Handle>10.1016/0893-133X(89)90031-6</Handle>
</Occurrence>
                </BibArticle>
                <BibUnstructured>Nomikos GG, Damsma G, Wenkstern D, Fibiger HC. Acute effects of bupropion on extracellular dopamine concentrations in rat striatum and nucleus accumbens studied by in vivo microdialysis.<Emphasis Type="Italic">Neuropsychopharmacology.</Emphasis> 1989;2:273–279.</BibUnstructured>
              </Citation>
              <Citation ID="CR36">
                <CitationNumber>36.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>JA</Initials>
                    <FamilyName>Ascher</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JO</Initials>
                    <FamilyName>Cole</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JN</Initials>
                    <FamilyName>Colin</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>1995</Year>
                  <ArticleTitle Language="En">Bupropion: a review of its mechanism of antidepressant activity</ArticleTitle>
                  <JournalTitle>J Clin Psychiatry.</JournalTitle>
                  <VolumeID>56</VolumeID>
                  <FirstPage>395</FirstPage>
                  <LastPage>401</LastPage>
                  <Occurrence Type="PID">
                    <Handle>7665537</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:STN:280:DyaK2MzpsVyksw%3D%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Ascher JA, Cole JO, Colin JN, et al. Bupropion: a review of its mechanism of antidepressant activity.<Emphasis Type="Italic">J Clin Psychiatry.</Emphasis> 1995;56:395–401.</BibUnstructured>
              </Citation>
              <Citation ID="CR37">
                <CitationNumber>37.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>SX</Initials>
                    <FamilyName>Li</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>KW</Initials>
                    <FamilyName>Perry</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>DT</Initials>
                    <FamilyName>Wong</FamilyName>
                  </BibAuthorName>
                  <Year>2002</Year>
                  <ArticleTitle Language="En">Influence of fluoxetine on the ability of bupropion to modulate extracellular dopamine and norepinephrine concentrations in three mesocorticolimbic areas of rats</ArticleTitle>
                  <JournalTitle>Neuropharmacology</JournalTitle>
                  <VolumeID>42</VolumeID>
                  <FirstPage>181</FirstPage>
                  <LastPage>190</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11804614</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD38Xms1aiuw%3D%3D</Handle>
                  </Occurrence>
<Occurrence Type="DOI">
<Handle>10.1016/S0028-3908(01)00160-5</Handle>
</Occurrence>
                </BibArticle>
                <BibUnstructured>Li SX, Perry KW, Wong DT. Influence of fluoxetine on the ability of bupropion to modulate extracellular dopamine and norepinephrine concentrations in three mesocorticolimbic areas of rats.<Emphasis Type="Italic">Neuropharmacology</Emphasis>. 2002;42:181–190.</BibUnstructured>
              </Citation>
              <Citation ID="CR38">
                <CitationNumber>38.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>MI</Initials>
                    <FamilyName>Damaj</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>FI</Initials>
                    <FamilyName>Carroll</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JB</Initials>
                    <FamilyName>Eaton</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2004</Year>
                  <ArticleTitle Language="En">Enantioselective effects of hydroxy metabolites of bupropion on behavior and on function of monoamine transporters and nicotinic receptors</ArticleTitle>
                  <JournalTitle>Mol Pharmacol</JournalTitle>
                  <VolumeID>66</VolumeID>
                  <FirstPage>675</FirstPage>
                  <LastPage>682</LastPage>
                  <Occurrence Type="PID">
                    <Handle>15322260</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2cXntlCksbk%3D</Handle>
                  </Occurrence>
<Occurrence Type="DOI">
<Handle>10.1124/mol.104.001313</Handle>
</Occurrence>
                </BibArticle>
                <BibUnstructured>Damaj MI, Carroll FI, Eaton JB, et al. Enantioselective effects of hydroxy metabolites of bupropion on behavior and on function of monoamine transporters and nicotinic receptors.<Emphasis Type="Italic">Mol Pharmacol</Emphasis>. 2004;66:675–682.</BibUnstructured>
              </Citation>
              <Citation ID="CR39">
                <CitationNumber>39.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>JD</Initials>
                    <FamilyName>Fryer</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>RJ</Initials>
                    <FamilyName>Lukas</FamilyName>
                  </BibAuthorName>
                  <Year>1999</Year>
                  <ArticleTitle Language="En">Noncompetitive functional inhibition at diverse, human nicotinic acetylcholine receptor subtypes by pupropion, phencyclidine, and ibogaine</ArticleTitle>
                  <JournalTitle>J Pharmacol Exp Ther.</JournalTitle>
                  <VolumeID>288</VolumeID>
                  <FirstPage>88</FirstPage>
                  <LastPage>92</LastPage>
                  <Occurrence Type="PID">
                    <Handle>9862757</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK1MXisVyksg%3D%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Fryer JD, Lukas RJ. Noncompetitive functional inhibition at diverse, human nicotinic acetylcholine receptor subtypes by pupropion, phencyclidine, and ibogaine.<Emphasis Type="Italic">J Pharmacol Exp Ther.</Emphasis> 1999;288:88–92.</BibUnstructured>
              </Citation>
              <Citation ID="CR40">
                <CitationNumber>40.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>JE</Initials>
                    <FamilyName>Slemmer</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>BR</Initials>
                    <FamilyName>Martin</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>MI</Initials>
                    <FamilyName>Damaj</FamilyName>
                  </BibAuthorName>
                  <Year>2000</Year>
                  <ArticleTitle Language="En">Bupropion is a nicotinic antagonist</ArticleTitle>
                  <JournalTitle>J Pharmacol Exp Ther.</JournalTitle>
                  <VolumeID>295</VolumeID>
                  <FirstPage>321</FirstPage>
                  <LastPage>327</LastPage>
                  <Occurrence Type="PID">
                    <Handle>10991997</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3cXnt1ynsrg%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Slemmer JE, Martin BR, Damaj MI. Bupropion is a nicotinic antagonist.<Emphasis Type="Italic">J Pharmacol Exp Ther.</Emphasis> 2000;295:321–327.</BibUnstructured>
              </Citation>
              <Citation ID="CR41">
                <CitationNumber>41.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>DK</Initials>
                    <FamilyName>Miller</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>SP</Initials>
                    <FamilyName>Sumithran</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>LP</Initials>
                    <FamilyName>Dwoskin</FamilyName>
                  </BibAuthorName>
                  <Year>2002</Year>
                  <ArticleTitle Language="En">Bupropion inhibits nicotine-evoked [(3)H]overflow from rat striatal slices preloaded with [(3)H]dopamine and from rat hippocampal slices preloaded with [(3)H]norepinephrine</ArticleTitle>
                  <JournalTitle>J Pharmacol Exp Ther.</JournalTitle>
                  <VolumeID>302</VolumeID>
                  <FirstPage>1113</FirstPage>
                  <LastPage>1122</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12183670</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD38XmsF2htrg%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Miller DK, Sumithran SP, Dwoskin LP. Bupropion inhibits nicotine-evoked [(3)H]overflow from rat striatal slices preloaded with [(3)H]dopamine and from rat hippocampal slices preloaded with [(3)H]norepinephrine.<Emphasis Type="Italic">J Pharmacol Exp Ther.</Emphasis> 2002;302:1113–1122.</BibUnstructured>
              </Citation>
              <Citation ID="CR42">
                <CitationNumber>42.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>F</Initials>
                    <FamilyName>Gumilar</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>HR</Initials>
                    <FamilyName>Arias</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>G</Initials>
                    <FamilyName>Spitzmaul</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>C</Initials>
                    <FamilyName>Bouzat</FamilyName>
                  </BibAuthorName>
                  <Year>2003</Year>
                  <ArticleTitle Language="En">Molecular mechanisms of inhibition of nicotinic acetylcholine receptors by tricyclic antidepressants</ArticleTitle>
                  <JournalTitle>Neuropharmacology</JournalTitle>
                  <VolumeID>45</VolumeID>
                  <FirstPage>964</FirstPage>
                  <LastPage>976</LastPage>
                  <Occurrence Type="PID">
                    <Handle>14573389</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3sXot1yrsbg%3D</Handle>
                  </Occurrence>
<Occurrence Type="DOI">
<Handle>10.1016/S0028-3908(03)00247-8</Handle>
</Occurrence>
                </BibArticle>
                <BibUnstructured>Gumilar F, Arias HR, Spitzmaul G, Bouzat C. Molecular mechanisms of inhibition of nicotinic acetylcholine receptors by tricyclic antidepressants.<Emphasis Type="Italic">Neuropharmacology</Emphasis>. 2003;45:964–976.</BibUnstructured>
              </Citation>
              <Citation ID="CR43">
                <CitationNumber>43.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>SR</Initials>
                    <FamilyName>Grady</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>MJ</Initials>
                    <FamilyName>Marks</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Wonnacott</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>AC</Initials>
                    <FamilyName>Collins</FamilyName>
                  </BibAuthorName>
                  <Year>1992</Year>
                  <ArticleTitle Language="En">Characterization of nicotinic receptor-mediated [<Superscript>3</Superscript>H]dopamine release from synaptosomes prepared from mouse striatum</ArticleTitle>
                  <JournalTitle>J Neurochem.</JournalTitle>
                  <VolumeID>59</VolumeID>
                  <FirstPage>848</FirstPage>
                  <LastPage>856</LastPage>
                  <Occurrence Type="PID">
                    <Handle>1494911</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK38XlsVCit7Y%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Grady SR, Marks MJ, Wonnacott S, Collins AC. Characterization of nicotinic receptor-mediated [<Superscript>3</Superscript>H]dopamine release from synaptosomes prepared from mouse striatum.<Emphasis Type="Italic">J Neurochem.</Emphasis> 1992;59:848–856.</BibUnstructured>
              </Citation>
              <Citation ID="CR44">
                <CitationNumber>44.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>L</Initials>
                    <FamilyName>Teng</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>PA</Initials>
                    <FamilyName>Crooks</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>ST</Initials>
                    <FamilyName>Buxton</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>LP</Initials>
                    <FamilyName>Dwoskin</FamilyName>
                  </BibAuthorName>
                  <Year>1997</Year>
                  <ArticleTitle Language="En">Nicotinic-receptor mediation of S(-)-nornicotine-evoked [<Superscript>3</Superscript>H]-overflow from rat striatal slices preloaded with [<Superscript>3</Superscript>H]-dopamine</ArticleTitle>
                  <JournalTitle>J Pharmacol Exp Ther.</JournalTitle>
                  <VolumeID>283</VolumeID>
                  <FirstPage>778</FirstPage>
                  <LastPage>787</LastPage>
                  <Occurrence Type="PID">
                    <Handle>9353398</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK2sXnsV2msb4%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Teng L, Crooks PA, Buxton ST, Dwoskin LP. Nicotinic-receptor mediation of S(-)-nornicotine-evoked [<Superscript>3</Superscript>H]-overflow from rat striatal slices preloaded with [<Superscript>3</Superscript>H]-dopamine.<Emphasis Type="Italic">J Pharmacol Exp Ther.</Emphasis> 1997;283:778–787.</BibUnstructured>
              </Citation>
              <Citation ID="CR45">
                <CitationNumber>45.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>LH</Initials>
                    <FamilyName>Wilkins</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Haubner</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JT</Initials>
                    <FamilyName>Ayers</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>PA</Initials>
                    <FamilyName>Crooks</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>LP</Initials>
                    <FamilyName>Dwoskin</FamilyName>
                  </BibAuthorName>
                  <Year>2002</Year>
                  <ArticleTitle Language="En">
                    <Emphasis Type="Italic">N-n</Emphasis>-Alkylnicotinium analogs, a novel class of nicotinic receptor antagonist: Inhibition of S(-)-nicotine-evoked [<Superscript>3</Superscript>H]dopamine overflow from superfused rat striatal slices</ArticleTitle>
                  <JournalTitle>J Pharmacol Exp Ther.</JournalTitle>
                  <VolumeID>301</VolumeID>
                  <FirstPage>1088</FirstPage>
                  <LastPage>1096</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12023541</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD38XktlGjsbk%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Wilkins LH, Haubner A, Ayers JT, Crooks PA, Dwoskin LP.<Emphasis Type="Italic">N-n</Emphasis>-Alkylnicotinium analogs, a novel class of nicotinic receptor antagonist: Inhibition of S(-)-nicotine-evoked [<Superscript>3</Superscript>H]dopamine overflow from superfused rat striatal slices.<Emphasis Type="Italic">J Pharmacol Exp Ther.</Emphasis> 2002;301:1088–1096.</BibUnstructured>
              </Citation>
              <Citation ID="CR46">
                <CitationNumber>46.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>JE</Initials>
                    <FamilyName>Rose</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>FM</Initials>
                    <FamilyName>Behm</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>EC</Initials>
                    <FamilyName>Westman</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>ED</Initials>
                    <FamilyName>Levin</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>RM</Initials>
                    <FamilyName>Stein</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>GV</Initials>
                    <FamilyName>Ripka</FamilyName>
                  </BibAuthorName>
                  <Year>1994</Year>
                  <ArticleTitle Language="En">Mecamylamine combined with nicotine skin patch facilitates smoking cessation beyond nicotine patch treatment alone</ArticleTitle>
                  <JournalTitle>Clin Pharmacol Ther.</JournalTitle>
                  <VolumeID>56</VolumeID>
                  <FirstPage>86</FirstPage>
                  <LastPage>99</LastPage>
                  <Occurrence Type="PID">
                    <Handle>8033499</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK2cXmslWqurs%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1038/clpt.1994.105</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Rose JE, Behm FM, Westman EC, Levin ED, Stein RM, Ripka GV. Mecamylamine combined with nicotine skin patch facilitates smoking cessation beyond nicotine patch treatment alone.<Emphasis Type="Italic">Clin Pharmacol Ther.</Emphasis> 1994;56:86–99.</BibUnstructured>
              </Citation>
              <Citation ID="CR47">
                <CitationNumber>47.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>JE</Initials>
                    <FamilyName>Rose</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>EC</Initials>
                    <FamilyName>Westman</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>FM</Initials>
                    <FamilyName>Behm</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>MP</Initials>
                    <FamilyName>Johnson</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JS</Initials>
                    <FamilyName>Goldberg</FamilyName>
                  </BibAuthorName>
                  <Year>1999</Year>
                  <ArticleTitle Language="En">Blockade of smoking satisfaction using the peripheral nicotinic antagonist trimethaphan</ArticleTitle>
                  <JournalTitle>Pharmacol Biochem Behav.</JournalTitle>
                  <VolumeID>62</VolumeID>
                  <FirstPage>165</FirstPage>
                  <LastPage>172</LastPage>
                  <Occurrence Type="PID">
                    <Handle>9972860</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK1cXnvFyltrs%3D</Handle>
                  </Occurrence>
<Occurrence Type="DOI">
<Handle>10.1016/S0091-3057(98)00153-1</Handle>
</Occurrence>
                </BibArticle>
                <BibUnstructured>Rose JE, Westman EC, Behm FM, Johnson MP, Goldberg JS. Blockade of smoking satisfaction using the peripheral nicotinic antagonist trimethaphan.<Emphasis Type="Italic">Pharmacol Biochem Behav.</Emphasis> 1999;62:165–172.</BibUnstructured>
              </Citation>
              <Citation ID="CR48">
                <CitationNumber>48.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>R</Initials>
                    <FamilyName>Anand</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>WG</Initials>
                    <FamilyName>Conroy</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>R</Initials>
                    <FamilyName>Schoepfer</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>P</Initials>
                    <FamilyName>Whiting</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J</Initials>
                    <FamilyName>Lindstrom</FamilyName>
                  </BibAuthorName>
                  <Year>1991</Year>
                  <ArticleTitle Language="En">Neuronal nicotinic acetylcholine receptors expressed in<Emphasis Type="Italic">Xenopus</Emphasis> oocytes have a pentameric quaternary structure</ArticleTitle>
                  <JournalTitle>J Biol Chem.</JournalTitle>
                  <VolumeID>266</VolumeID>
                  <FirstPage>11192</FirstPage>
                  <LastPage>11198</LastPage>
                  <Occurrence Type="PID">
                    <Handle>2040627</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK3MXks1Ort74%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Anand R, Conroy WG, Schoepfer R, Whiting P, Lindstrom J. Neuronal nicotinic acetylcholine receptors expressed in<Emphasis Type="Italic">Xenopus</Emphasis> oocytes have a pentameric quaternary structure.<Emphasis Type="Italic">J Biol Chem.</Emphasis> 1991;266:11192–11198.</BibUnstructured>
              </Citation>
              <Citation ID="CR49">
                <CitationNumber>49.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>E</Initials>
                    <FamilyName>Cooper</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Couturier</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Ballivet</FamilyName>
                  </BibAuthorName>
                  <Year>1991</Year>
                  <ArticleTitle Language="En">Pentameric structure and subunit stoichiometry of a neuronal nicotinic acetylcholine receptor</ArticleTitle>
                  <JournalTitle>Nature</JournalTitle>
                  <VolumeID>350</VolumeID>
                  <FirstPage>235</FirstPage>
                  <LastPage>238</LastPage>
                  <Occurrence Type="PID">
                    <Handle>2005979</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK3MXisVejsbY%3D</Handle>
                  </Occurrence>
<Occurrence Type="DOI">
<Handle>10.1038/350235a0</Handle>
</Occurrence>
                </BibArticle>
                <BibUnstructured>Cooper E, Couturier S, Ballivet M. Pentameric structure and subunit stoichiometry of a neuronal nicotinic acetylcholine receptor.<Emphasis Type="Italic">Nature</Emphasis>. 1991;350:235–238.</BibUnstructured>
              </Citation>
              <Citation ID="CR50">
                <CitationNumber>50.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>JP</Initials>
                    <FamilyName>Boorman</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>PJ</Initials>
                    <FamilyName>Groot-Kormelink</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>LG</Initials>
                    <FamilyName>Sivilotti</FamilyName>
                  </BibAuthorName>
                  <Year>2000</Year>
                  <ArticleTitle Language="En">Stoichiometry of human recombinant neuronal nicotinic receptors containing the β3 subunit expressed in Xenopus oocytes</ArticleTitle>
                  <JournalTitle>J Physiol</JournalTitle>
                  <VolumeID>529</VolumeID>
                  <FirstPage>565</FirstPage>
                  <LastPage>577</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11118490</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3MXjslyquw%3D%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Boorman JP, Groot-Kormelink PJ, Sivilotti LG. Stoichiometry of human recombinant neuronal nicotinic receptors containing the β3 subunit expressed in Xenopus oocytes.<Emphasis Type="Italic">J Physiol</Emphasis>. 2000;529:565–577.</BibUnstructured>
              </Citation>
              <Citation ID="CR51">
                <CitationNumber>51.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>DC</Initials>
                    <FamilyName>Perry</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>Y</Initials>
                    <FamilyName>Xiao</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>HN</Initials>
                    <FamilyName>Nguyen</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JL</Initials>
                    <FamilyName>Musachio</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>MI</Initials>
                    <FamilyName>Davila-Garcia</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>KJ</Initials>
                    <FamilyName>Kellar</FamilyName>
                  </BibAuthorName>
                  <Year>2002</Year>
                  <ArticleTitle Language="En">Measuring nicotinic receptors with characteristics of alpha4beta2, alpha3beta2 and alpha3beta4 subtypes in rat tissues by autoradiography</ArticleTitle>
                  <JournalTitle>J Neurochem</JournalTitle>
                  <VolumeID>82</VolumeID>
                  <FirstPage>468</FirstPage>
                  <LastPage>481</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12153472</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD38Xmt1ejs7s%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Perry DC, Xiao Y, Nguyen HN, Musachio JL, Davila-Garcia MI, Kellar KJ. Measuring nicotinic receptors with characteristics of alpha4beta2, alpha3beta2 and alpha3beta4 subtypes in rat tissues by autoradiography.<Emphasis Type="Italic">J Neurochem</Emphasis>. 2002;82:468–481.</BibUnstructured>
              </Citation>
              <Citation ID="CR52">
                <CitationNumber>52.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>N</Initials>
                    <FamilyName>Novere</FamilyName>
                    <Particle>Le</Particle>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JP</Initials>
                    <FamilyName>Changeux</FamilyName>
                  </BibAuthorName>
                  <Year>1995</Year>
                  <ArticleTitle Language="En">Molecular evolution of the nicotinic acetylcholine receptor: an example of multigene family in excitable cells</ArticleTitle>
                  <JournalTitle>J Mol Evol.</JournalTitle>
                  <VolumeID>40</VolumeID>
                  <FirstPage>155</FirstPage>
                  <LastPage>172</LastPage>
                  <Occurrence Type="PID">
                    <Handle>7699721</Handle>
                  </Occurrence>
<Occurrence Type="DOI">
<Handle>10.1007/BF00167110</Handle>
</Occurrence>
                </BibArticle>
                <BibUnstructured>Le Novere N, Changeux JP. Molecular evolution of the nicotinic acetylcholine receptor: an example of multigene family in excitable cells.<Emphasis Type="Italic">J Mol Evol.</Emphasis> 1995;40:155–172.</BibUnstructured>
              </Citation>
              <Citation ID="CR53">
                <CitationNumber>53.</CitationNumber>
                <BibChapter>
                  <BibAuthorName>
                    <Initials>J</Initials>
                    <FamilyName>Lindstrom</FamilyName>
                  </BibAuthorName>
                  <Year>1996</Year>
                  <ChapterTitle Language="En">Neuronal nicotinic acetylcholine receptors</ChapterTitle>
                  <BibEditorName>
                    <Initials>T</Initials>
                    <FamilyName>Narahashi</FamilyName>
                  </BibEditorName>
                  <Eds/>
                  <BookTitle>Ion Channels</BookTitle>
                  <PublisherName>Plenum Press</PublisherName>
                  <PublisherLocation>New York, NY</PublisherLocation>
                  <FirstPage>377</FirstPage>
                  <LastPage>450</LastPage>
                </BibChapter>
                <BibUnstructured>Lindstrom J. Neuronal nicotinic acetylcholine receptors. In: Narahashi T, ed.<Emphasis Type="Italic">Ion Channels</Emphasis>. vol. 4. New York, NY: Plenum Press; 1996:377–450.</BibUnstructured>
              </Citation>
              <Citation ID="CR54">
                <CitationNumber>54.</CitationNumber>
                <BibChapter>
                  <BibAuthorName>
                    <Initials>J</Initials>
                    <FamilyName>Lindstrom</FamilyName>
                  </BibAuthorName>
                  <Year>2000</Year>
                  <ChapterTitle Language="En">The structures of neuronal nicotinic receptors</ChapterTitle>
                  <BibEditorName>
                    <Initials>F</Initials>
                    <FamilyName>Clementi</FamilyName>
                  </BibEditorName>
                  <BibEditorName>
                    <Initials>D</Initials>
                    <FamilyName>Fornasari</FamilyName>
                  </BibEditorName>
                  <BibEditorName>
                    <Initials>C</Initials>
                    <FamilyName>Gotti</FamilyName>
                  </BibEditorName>
                  <Eds/>
                  <BookTitle>Handbook of Experimental Pharmacology: Neuronal Nicotinic Receptors</BookTitle>
                  <PublisherName>Springer</PublisherName>
                  <PublisherLocation>Berlin, Germany</PublisherLocation>
                  <FirstPage>101</FirstPage>
                  <LastPage>162</LastPage>
                </BibChapter>
                <BibUnstructured>Lindstrom J. The structures of neuronal nicotinic receptors. In: Clementi F, Fornasari D, Gotti C, eds.<Emphasis Type="Italic">Handbook of Experimental Pharmacology: Neuronal Nicotinic Receptors</Emphasis>, vol. 144. Berlin, Germany: Springer; 2000:101–162.</BibUnstructured>
              </Citation>
              <Citation ID="CR55">
                <CitationNumber>55.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>AB</Initials>
                    <FamilyName>Elgoyhen</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>DE</Initials>
                    <FamilyName>Vetter</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>E</Initials>
                    <FamilyName>Katz</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>CV</Initials>
                    <FamilyName>Rothlin</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>SF</Initials>
                    <FamilyName>Heinemann</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J</Initials>
                    <FamilyName>Boulter</FamilyName>
                  </BibAuthorName>
                  <Year>2001</Year>
                  <ArticleTitle Language="En">α10: a determinant of nicotinic cholinergic receptor function in mammalian vestibular and cochlear mechanosensory hair cells</ArticleTitle>
                  <JournalTitle>Proc Natl Acad Sci USA.</JournalTitle>
                  <VolumeID>98</VolumeID>
                  <FirstPage>3501</FirstPage>
                  <LastPage>3506</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11248107</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3MXit1alu7Y%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Elgoyhen AB, Vetter DE, Katz E, Rothlin CV, Heinemann SF, Boulter J. α10: a determinant of nicotinic cholinergic receptor function in mammalian vestibular and cochlear mechanosensory hair cells.<Emphasis Type="Italic">Proc Natl Acad Sci USA.</Emphasis> 2001;98:3501–3506.</BibUnstructured>
              </Citation>
              <Citation ID="CR56">
                <CitationNumber>56.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>CW</Initials>
                    <FamilyName>Luetje</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J</Initials>
                    <FamilyName>Patrick</FamilyName>
                  </BibAuthorName>
                  <Year>1991</Year>
                  <ArticleTitle Language="En">Both alpha and beta-subunits contribute to the agonist sensitivity of neuronal nicotinic acetylcholine receptors</ArticleTitle>
                  <JournalTitle>J Neurosci.</JournalTitle>
                  <VolumeID>11</VolumeID>
                  <FirstPage>837</FirstPage>
                  <LastPage>845</LastPage>
                  <Occurrence Type="PID">
                    <Handle>1705971</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK3MXlt1yjs7c%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Luetje CW, Patrick J. Both alpha and beta-subunits contribute to the agonist sensitivity of neuronal nicotinic acetylcholine receptors.<Emphasis Type="Italic">J Neurosci.</Emphasis> 1991;11:837–845.</BibUnstructured>
              </Citation>
              <Citation ID="CR57">
                <CitationNumber>57.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>SC</Initials>
                    <FamilyName>Harvey</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>CW</Initials>
                    <FamilyName>Luetje</FamilyName>
                  </BibAuthorName>
                  <Year>1996</Year>
                  <ArticleTitle Language="En">Determinants of competitive antagonist sensitivity on neuronal nicotinic receptorβ subunits</ArticleTitle>
                  <JournalTitle>J Neurosci.</JournalTitle>
                  <VolumeID>16</VolumeID>
                  <FirstPage>3798</FirstPage>
                  <LastPage>3806</LastPage>
                  <Occurrence Type="PID">
                    <Handle>8656274</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK28XjsFGisr4%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Harvey SC, Luetje CW. Determinants of competitive antagonist sensitivity on neuronal nicotinic receptorβ subunits.<Emphasis Type="Italic">J Neurosci.</Emphasis> 1996;16:3798–3806.</BibUnstructured>
              </Citation>
              <Citation ID="CR58">
                <CitationNumber>58.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>J</Initials>
                    <FamilyName>Ramirez-Latorre</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>CR</Initials>
                    <FamilyName>Yu</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>X</Initials>
                    <FamilyName>Qu</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>F</Initials>
                    <FamilyName>Perin</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Karlin</FamilyName>
                  </BibAuthorName>
                  <Year>1996</Year>
                  <ArticleTitle Language="En">Functional contributions of α5 subunit to neuronal acetylcholine receptor channels</ArticleTitle>
                  <JournalTitle>Nature</JournalTitle>
                  <VolumeID>380</VolumeID>
                  <FirstPage>347</FirstPage>
                  <LastPage>351</LastPage>
                  <Occurrence Type="PID">
                    <Handle>8598930</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK28XhvFyrt7Y%3D</Handle>
                  </Occurrence>
<Occurrence Type="DOI">
<Handle>10.1038/380347a0</Handle>
</Occurrence>
                </BibArticle>
                <BibUnstructured>Ramirez-Latorre J, Yu CR, Qu X, Perin F, Karlin A. Functional contributions of α5 subunit to neuronal acetylcholine receptor channels.<Emphasis Type="Italic">Nature</Emphasis>. 1996;380:347–351.</BibUnstructured>
              </Citation>
              <Citation ID="CR59">
                <CitationNumber>59.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>LE</Initials>
                    <FamilyName>Chavez-Noriega</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JH</Initials>
                    <FamilyName>Crona</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>MS</Initials>
                    <FamilyName>Washburn</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Urrutia</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>KJ</Initials>
                    <FamilyName>Elliott</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>EC</Initials>
                    <FamilyName>Johnson</FamilyName>
                  </BibAuthorName>
                  <Year>1997</Year>
                  <ArticleTitle Language="En">Pharmacological characterization of recombinant human neuronal nicotinic acetylcholine receptors hα2β2, hα2β4, hα3β2, hα3β4, hα4β2, hα4β4 and hα7 expressed in Xenopus oocytes</ArticleTitle>
                  <JournalTitle>J Pharmacol Exp Ther.</JournalTitle>
                  <VolumeID>280</VolumeID>
                  <FirstPage>346</FirstPage>
                  <LastPage>356</LastPage>
                  <Occurrence Type="PID">
                    <Handle>8996215</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK2sXntFGrug%3D%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Chavez-Noriega LE, Crona JH, Washburn MS, Urrutia A, Elliott KJ, Johnson EC. Pharmacological characterization of recombinant human neuronal nicotinic acetylcholine receptors hα2β2, hα2β4, hα3β2, hα3β4, hα4β2, hα4β4 and hα7 expressed in Xenopus oocytes.<Emphasis Type="Italic">J Pharmacol Exp Ther.</Emphasis> 1997;280:346–356.</BibUnstructured>
              </Citation>
              <Citation ID="CR60">
                <CitationNumber>60.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Kuryatov</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>F</Initials>
                    <FamilyName>Olale</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J</Initials>
                    <FamilyName>Cooper</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J</Initials>
                    <FamilyName>Choi</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J</Initials>
                    <FamilyName>Lindstrom</FamilyName>
                  </BibAuthorName>
                  <Year>2000</Year>
                  <ArticleTitle Language="En">Human α6 subtypes: subunit composition, assembly and pharmacological responses</ArticleTitle>
                  <JournalTitle>Neuropharmacology</JournalTitle>
                  <VolumeID>39</VolumeID>
                  <FirstPage>2570</FirstPage>
                  <LastPage>2590</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11044728</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3cXntlGqsL4%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Kuryatov A, Olale F, Cooper J, Choi J, Lindstrom J. Human α6 subtypes: subunit composition, assembly and pharmacological responses.<Emphasis Type="Italic">Neuropharmacology</Emphasis>. 2000;39:2570–2590.</BibUnstructured>
              </Citation>
              <Citation ID="CR61">
                <CitationNumber>61.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>RL</Initials>
                    <FamilyName>Papke</FamilyName>
                  </BibAuthorName>
                  <Year>1993</Year>
                  <ArticleTitle Language="En">The kinetic properties of neuronal nicotinic receptors: genetic basis of functional diversity</ArticleTitle>
                  <JournalTitle>Prog Neurobiol</JournalTitle>
                  <VolumeID>41</VolumeID>
                  <FirstPage>509</FirstPage>
                  <LastPage>531</LastPage>
                  <Occurrence Type="PID">
                    <Handle>7692467</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK3sXlvFGktbY%3D</Handle>
                  </Occurrence>
<Occurrence Type="DOI">
<Handle>10.1016/0301-0082(93)90028-Q</Handle>
</Occurrence>
                </BibArticle>
                <BibUnstructured>Papke RL. The kinetic properties of neuronal nicotinic receptors: genetic basis of functional diversity.<Emphasis Type="Italic">Prog Neurobiol</Emphasis>. 1993;41:509–531.</BibUnstructured>
              </Citation>
              <Citation ID="CR62">
                <CitationNumber>62.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>F</Initials>
                    <FamilyName>Sgard</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>E</Initials>
                    <FamilyName>Charpantier</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Bertrand</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2002</Year>
                  <ArticleTitle Language="En">A novel human nicotinic receptor subunit, α10 that confers functionality to the α9-subunit</ArticleTitle>
                  <JournalTitle>Mol Pharmacol</JournalTitle>
                  <VolumeID>61</VolumeID>
                  <FirstPage>150</FirstPage>
                  <LastPage>159</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11752216</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD38XltlWl</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Sgard F, Charpantier E, Bertrand S, et al. A novel human nicotinic receptor subunit, α10 that confers functionality to the α9-subunit.<Emphasis Type="Italic">Mol Pharmacol</Emphasis>. 2002;61:150–159.</BibUnstructured>
              </Citation>
              <Citation ID="CR63">
                <CitationNumber>63.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>P</Initials>
                    <FamilyName>Whiting</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>R</Initials>
                    <FamilyName>Schoepfer</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J</Initials>
                    <FamilyName>Lindstrom</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>T</Initials>
                    <FamilyName>Priestley</FamilyName>
                  </BibAuthorName>
                  <Year>1991</Year>
                  <ArticleTitle Language="En">Structural and pharmacological characterization of the major brain nicotinic acetylcholine receptor subtype stably expressed in mouse fibroblasts</ArticleTitle>
                  <JournalTitle>Mol Pharmacol</JournalTitle>
                  <VolumeID>40</VolumeID>
                  <FirstPage>463</FirstPage>
                  <LastPage>472</LastPage>
                  <Occurrence Type="PID">
                    <Handle>1717818</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK3MXmsVylsL0%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Whiting P, Schoepfer R, Lindstrom J, Priestley T. Structural and pharmacological characterization of the major brain nicotinic acetylcholine receptor subtype stably expressed in mouse fibroblasts.<Emphasis Type="Italic">Mol Pharmacol</Emphasis>. 1991;40:463–472.</BibUnstructured>
              </Citation>
              <Citation ID="CR64">
                <CitationNumber>64.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>CM</Initials>
                    <FamilyName>Flores</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>SW</Initials>
                    <FamilyName>Rogers</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>LA</Initials>
                    <FamilyName>Pabreza</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>BB</Initials>
                    <FamilyName>Wolfe</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>KJ</Initials>
                    <FamilyName>Kellar</FamilyName>
                  </BibAuthorName>
                  <Year>1992</Year>
                  <ArticleTitle Language="En">A subtype of nicotinic cholinergic receptor in rat brain is composed of α4 and β2 subunits and is up-regulated by chronic nicotine treatment</ArticleTitle>
                  <JournalTitle>Mol Pharmacol</JournalTitle>
                  <VolumeID>41</VolumeID>
                  <FirstPage>31</FirstPage>
                  <LastPage>37</LastPage>
                  <Occurrence Type="PID">
                    <Handle>1732720</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK38Xls1Cmu7s%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Flores CM, Rogers SW, Pabreza LA, Wolfe BB, Kellar KJ. A subtype of nicotinic cholinergic receptor in rat brain is composed of α4 and β2 subunits and is up-regulated by chronic nicotine treatment.<Emphasis Type="Italic">Mol Pharmacol</Emphasis>. 1992;41:31–37.</BibUnstructured>
              </Citation>
              <Citation ID="CR65">
                <CitationNumber>65.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>X</Initials>
                    <FamilyName>Peng</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>V</Initials>
                    <FamilyName>Gerzanich</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>R</Initials>
                    <FamilyName>Anand</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>PJ</Initials>
                    <FamilyName>Whiting</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J</Initials>
                    <FamilyName>Lindstrom</FamilyName>
                  </BibAuthorName>
                  <Year>1994</Year>
                  <ArticleTitle Language="En">Nicotine-induced increase in the neuronal nicotinic receptors results from a decrease in the rate of receptor turnover</ArticleTitle>
                  <JournalTitle>Mol Pharmacol</JournalTitle>
                  <VolumeID>46</VolumeID>
                  <FirstPage>523</FirstPage>
                  <LastPage>530</LastPage>
                  <Occurrence Type="PID">
                    <Handle>7935334</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK2cXmt1Cit7c%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Peng X, Gerzanich V, Anand R, Whiting PJ, Lindstrom J. Nicotine-induced increase in the neuronal nicotinic receptors results from a decrease in the rate of receptor turnover.<Emphasis Type="Italic">Mol Pharmacol</Emphasis>. 1994;46:523–530.</BibUnstructured>
              </Citation>
              <Citation ID="CR66">
                <CitationNumber>66.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>AR</Initials>
                    <FamilyName>Davies</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>DJ</Initials>
                    <FamilyName>Hardick</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>IS</Initials>
                    <FamilyName>Blagbrough</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>BV</Initials>
                    <FamilyName>Potter</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>AJ</Initials>
                    <FamilyName>Wolstenholme</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Wonnacott</FamilyName>
                  </BibAuthorName>
                  <Year>1999</Year>
                  <ArticleTitle Language="En">Characterization of the binding of [<Superscript>3</Superscript>H]methyllycaconitine: a new radioligand for labeling α7-type neuronal nicotinic acetylcholine receptors</ArticleTitle>
                  <JournalTitle>Neuropharmacology</JournalTitle>
                  <VolumeID>38</VolumeID>
                  <FirstPage>679</FirstPage>
                  <LastPage>690</LastPage>
                  <Occurrence Type="PID">
                    <Handle>10340305</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK1MXivVOkurY%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Davies AR, Hardick DJ, Blagbrough IS, Potter BV, Wolstenholme AJ, Wonnacott S. Characterization of the binding of [<Superscript>3</Superscript>H]methyllycaconitine: a new radioligand for labeling α7-type neuronal nicotinic acetylcholine receptors.<Emphasis Type="Italic">Neuropharmacology</Emphasis>. 1999;38:679–690.</BibUnstructured>
              </Citation>
              <Citation ID="CR67">
                <CitationNumber>67.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>E</Initials>
                    <FamilyName>Wada</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>K</Initials>
                    <FamilyName>Wada</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J</Initials>
                    <FamilyName>Boulter</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>1989</Year>
                  <ArticleTitle Language="En">Distribution of alpha 2, alpha 3, alpha 4 and beta 2 neuronal nicotinic receptor subunit mRNAs in the central nervous system: A hybridization histochemical study in the rat</ArticleTitle>
                  <JournalTitle>J Comp Neurol</JournalTitle>
                  <VolumeID>284</VolumeID>
                  <FirstPage>314</FirstPage>
                  <LastPage>335</LastPage>
                  <Occurrence Type="PID">
                    <Handle>2754038</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaL1MXlsVOhsbg%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Wada E, Wada K, Boulter J, et al. Distribution of alpha 2, alpha 3, alpha 4 and beta 2 neuronal nicotinic receptor subunit mRNAs in the central nervous system: A hybridization histochemical study in the rat.<Emphasis Type="Italic">J Comp Neurol</Emphasis>. 1989;284:314–335.</BibUnstructured>
              </Citation>
              <Citation ID="CR68">
                <CitationNumber>68.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>ES</Initials>
                    <FamilyName>Deneris</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J</Initials>
                    <FamilyName>Boulter</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>LW</Initials>
                    <FamilyName>Swanson</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J</Initials>
                    <FamilyName>Patrick</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Heinemann</FamilyName>
                  </BibAuthorName>
                  <Year>1989</Year>
                  <ArticleTitle Language="En">β3: a new member of nicotinic acetylcholine receptor gene family is expressed in brain</ArticleTitle>
                  <JournalTitle>J Biol Chem</JournalTitle>
                  <VolumeID>264</VolumeID>
                  <FirstPage>6268</FirstPage>
                  <LastPage>6272</LastPage>
                  <Occurrence Type="PID">
                    <Handle>2703489</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK3cXkvFKktw%3D%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Deneris ES, Boulter J, Swanson LW, Patrick J, Heinemann S. β3: a new member of nicotinic acetylcholine receptor gene family is expressed in brain.<Emphasis Type="Italic">J Biol Chem</Emphasis>. 1989;264:6268–6272.</BibUnstructured>
              </Citation>
              <Citation ID="CR69">
                <CitationNumber>69.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>R</Initials>
                    <FamilyName>Klink</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>AA</Initials>
                    <FamilyName>d'Exaerde</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Zoli</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JP</Initials>
                    <FamilyName>Changeux</FamilyName>
                  </BibAuthorName>
                  <Year>2001</Year>
                  <ArticleTitle Language="En">Molecular and physiological diversity of nicotinic acetylcholine receptors in the midbrain dopaminergic nuclei</ArticleTitle>
                  <JournalTitle>J Neurosci</JournalTitle>
                  <VolumeID>21</VolumeID>
                  <FirstPage>1452</FirstPage>
                  <LastPage>1463</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11222635</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3MXjslCltLk%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Klink R, d'Exaerde AA, Zoli M, Changeux JP. Molecular and physiological diversity of nicotinic acetylcholine receptors in the midbrain dopaminergic nuclei.<Emphasis Type="Italic">J Neurosci</Emphasis>. 2001;21:1452–1463.</BibUnstructured>
              </Citation>
              <Citation ID="CR70">
                <CitationNumber>70.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>L</Initials>
                    <FamilyName>Azam</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>UH</Initials>
                    <FamilyName>Winzer-Serjhan</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>Y</Initials>
                    <FamilyName>Chen</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>FM</Initials>
                    <FamilyName>Leslie</FamilyName>
                  </BibAuthorName>
                  <Year>2002</Year>
                  <ArticleTitle Language="En">Expression of neuronal nicotinic acetylcholine receptor subunit mRNAs within midbrain dopamine neurons</ArticleTitle>
                  <JournalTitle>J Comp Neurol</JournalTitle>
                  <VolumeID>444</VolumeID>
                  <FirstPage>260</FirstPage>
                  <LastPage>274</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11840479</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD38XitFOks7w%3D</Handle>
                  </Occurrence>
<Occurrence Type="DOI">
<Handle>10.1002/cne.10138</Handle>
</Occurrence>
                </BibArticle>
                <BibUnstructured>Azam L, Winzer-Serjhan UH, Chen Y, Leslie FM. Expression of neuronal nicotinic acetylcholine receptor subunit mRNAs within midbrain dopamine neurons.<Emphasis Type="Italic">J Comp Neurol</Emphasis>. 2002;444:260–274.</BibUnstructured>
              </Citation>
              <Citation ID="CR71">
                <CitationNumber>71.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>RJ</Initials>
                    <FamilyName>Lukas</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JP</Initials>
                    <FamilyName>Changeux</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>N</Initials>
                    <FamilyName>Novere</FamilyName>
                    <Particle>Le</Particle>
                  </BibAuthorName>
                  <Etal/>
                  <Year>1999</Year>
                  <ArticleTitle Language="En">International Union of Pharmacology. XX. Current status of the nomenclature for nicotinic acetylcholine receptors and their subunits</ArticleTitle>
                  <JournalTitle>Pharmacol Rev</JournalTitle>
                  <VolumeID>51</VolumeID>
                  <FirstPage>397</FirstPage>
                  <LastPage>401</LastPage>
                  <Occurrence Type="PID">
                    <Handle>10353988</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3cXnslChtro%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Lukas RJ, Changeux JP, Le Novere N, et al. International Union of Pharmacology. XX. Current status of the nomenclature for nicotinic acetylcholine receptors and their subunits.<Emphasis Type="Italic">Pharmacol Rev</Emphasis>. 1999;51:397–401.</BibUnstructured>
              </Citation>
              <Citation ID="CR72">
                <CitationNumber>72.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>JM</Initials>
                    <FamilyName>Kulak</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>TA</Initials>
                    <FamilyName>Nguyen</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>BM</Initials>
                    <FamilyName>Olivera</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JM</Initials>
                    <FamilyName>McIntosh</FamilyName>
                  </BibAuthorName>
                  <Year>1997</Year>
                  <ArticleTitle Language="En">Alpha-conotoxin MII blocks nicotine-stimulated dopamine release in rat striatal synaptosomes</ArticleTitle>
                  <JournalTitle>J Neurosci</JournalTitle>
                  <VolumeID>17</VolumeID>
                  <FirstPage>5263</FirstPage>
                  <LastPage>5270</LastPage>
                  <Occurrence Type="PID">
                    <Handle>9204910</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK2sXksVSgsbg%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Kulak JM, Nguyen TA, Olivera BM, McIntosh JM. Alpha-conotoxin MII blocks nicotine-stimulated dopamine release in rat striatal synaptosomes.<Emphasis Type="Italic">J Neurosci</Emphasis>. 1997;17:5263–5270.</BibUnstructured>
              </Citation>
              <Citation ID="CR73">
                <CitationNumber>73.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>SA</Initials>
                    <FamilyName>Kaiser</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>L</Initials>
                    <FamilyName>Soliakov</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>SC</Initials>
                    <FamilyName>Harvey</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>CW</Initials>
                    <FamilyName>Luetje</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Wonnacott</FamilyName>
                  </BibAuthorName>
                  <Year>1998</Year>
                  <ArticleTitle Language="En">Differential inhibition by α-conotoxin-MII of the nicotinic stimulation of [<Superscript>3</Superscript>H]dopamine release from rat striatal synaptosomes and slices</ArticleTitle>
                  <JournalTitle>J Neurochem</JournalTitle>
                  <VolumeID>70</VolumeID>
                  <FirstPage>1069</FirstPage>
                  <LastPage>1076</LastPage>
                  <Occurrence Type="PID">
                    <Handle>9489727</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK1cXht1yrtbo%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Kaiser SA, Soliakov L, Harvey SC, Luetje CW, Wonnacott S. Differential inhibition by α-conotoxin-MII of the nicotinic stimulation of [<Superscript>3</Superscript>H]dopamine release from rat striatal synaptosomes and slices.<Emphasis Type="Italic">J Neurochem</Emphasis>. 1998;70:1069–1076.</BibUnstructured>
              </Citation>
              <Citation ID="CR74">
                <CitationNumber>74.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>SR</Initials>
                    <FamilyName>Grady</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>NM</Initials>
                    <FamilyName>Meinerz</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J</Initials>
                    <FamilyName>Cao</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2001</Year>
                  <ArticleTitle Language="En">Nicotine agonists stimulate acetylcholine release from mouse interpeduncular nucleus: a function mediated by a different nAChR than dopamine release from striatum</ArticleTitle>
                  <JournalTitle>J Neurochem</JournalTitle>
                  <VolumeID>76</VolumeID>
                  <FirstPage>258</FirstPage>
                  <LastPage>268</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11145999</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3MXhtVGlsbc%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Grady SR, Meinerz NM, Cao J, et al. Nicotine agonists stimulate acetylcholine release from mouse interpeduncular nucleus: a function mediated by a different nAChR than dopamine release from striatum.<Emphasis Type="Italic">J Neurochem</Emphasis>. 2001;76:258–268.</BibUnstructured>
              </Citation>
              <Citation ID="CR75">
                <CitationNumber>75.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>VP</Initials>
                    <FamilyName>Grinevich</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>PA</Initials>
                    <FamilyName>Crooks</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>SP</Initials>
                    <FamilyName>Sumithran</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>AJ</Initials>
                    <FamilyName>Haubner</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JT</Initials>
                    <FamilyName>Ayers</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>LP</Initials>
                    <FamilyName>Dwoskin</FamilyName>
                  </BibAuthorName>
                  <Year>2003</Year>
                  <ArticleTitle Language="En">
                    <Emphasis Type="Italic">N-n</Emphasis>-Alkylpyridinium analogs, a novel class of nicotinic receptor antagonists: selective inhibition of nicotine-evoked [<Superscript>3</Superscript>H]dopamine overflow from superfused rat striatal slices</ArticleTitle>
                  <JournalTitle>J Pharmacol Exp Ther</JournalTitle>
                  <VolumeID>306</VolumeID>
                  <FirstPage>1011</FirstPage>
                  <LastPage>1020</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12766255</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3sXmvVeht70%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Grinevich VP, Crooks PA, Sumithran SP, Haubner AJ, Ayers JT, Dwoskin LP.<Emphasis Type="Italic">N-n</Emphasis>-Alkylpyridinium analogs, a novel class of nicotinic receptor antagonists: selective inhibition of nicotine-evoked [<Superscript>3</Superscript>H]dopamine overflow from superfused rat striatal slices.<Emphasis Type="Italic">J Pharmacol Exp Ther</Emphasis>. 2003;306:1011–1020.</BibUnstructured>
              </Citation>
              <Citation ID="CR76">
                <CitationNumber>76.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>LP</Initials>
                    <FamilyName>Dwoskin</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>SP</Initials>
                    <FamilyName>Sumithran</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J</Initials>
                    <FamilyName>Zhu</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>AG</Initials>
                    <FamilyName>Deaciuc</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JT</Initials>
                    <FamilyName>Ayers</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>PA</Initials>
                    <FamilyName>Crooks</FamilyName>
                  </BibAuthorName>
                  <Year>2004</Year>
                  <ArticleTitle Language="En">Subtype-selective nicotinic receptor antagonists: potential as tobacco use cessation agents</ArticleTitle>
                  <JournalTitle>Bioorg Med Chem Lett</JournalTitle>
                  <VolumeID>14</VolumeID>
                  <FirstPage>1863</FirstPage>
                  <LastPage>1867</LastPage>
                  <Occurrence Type="PID">
                    <Handle>15050617</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2cXislSqtbo%3D</Handle>
                  </Occurrence>
<Occurrence Type="DOI">
<Handle>10.1016/j.bmcl.2003.10.073</Handle>
</Occurrence>
                </BibArticle>
                <BibUnstructured>Dwoskin LP, Sumithran SP, Zhu J, Deaciuc AG, Ayers JT, Crooks PA. Subtype-selective nicotinic receptor antagonists: potential as tobacco use cessation agents.<Emphasis Type="Italic">Bioorg Med Chem Lett</Emphasis>. 2004;14:1863–1867.</BibUnstructured>
              </Citation>
              <Citation ID="CR77">
                <CitationNumber>77.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>CW</Initials>
                    <FamilyName>Luetje</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>K</Initials>
                    <FamilyName>Wada</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Rogers</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>1990</Year>
                  <ArticleTitle Language="En">Neurotoxins distinguish between different neuronal nicotinic acetylcholine receptor subunit combinations</ArticleTitle>
                  <JournalTitle>J Neurochem</JournalTitle>
                  <VolumeID>55</VolumeID>
                  <FirstPage>632</FirstPage>
                  <LastPage>640</LastPage>
                  <Occurrence Type="PID">
                    <Handle>1973456</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK3cXlsVGkt7w%3D</Handle>
                  </Occurrence>
<Occurrence Type="DOI">
<Handle>10.1111/j.1471-4159.1990.tb04180.x</Handle>
</Occurrence>
                </BibArticle>
                <BibUnstructured>Luetje CW, Wada K, Rogers S, et al. Neurotoxins distinguish between different neuronal nicotinic acetylcholine receptor subunit combinations.<Emphasis Type="Italic">J Neurochem</Emphasis>. 1990;55:632–640.</BibUnstructured>
              </Citation>
              <Citation ID="CR78">
                <CitationNumber>78.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>GE</Initials>
                    <FamilyName>Cartier</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>D</Initials>
                    <FamilyName>Yoshikami</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>WR</Initials>
                    <FamilyName>Gray</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Luo</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>BM</Initials>
                    <FamilyName>Olivera</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JM</Initials>
                    <FamilyName>McIntosh</FamilyName>
                  </BibAuthorName>
                  <Year>1996</Year>
                  <ArticleTitle Language="En">A new α-conotoxin which targets α3β2 nicotinic acetylcholine receptors</ArticleTitle>
                  <JournalTitle>J Biol Chem</JournalTitle>
                  <VolumeID>271</VolumeID>
                  <FirstPage>7522</FirstPage>
                  <LastPage>7528</LastPage>
                  <Occurrence Type="PID">
                    <Handle>8631783</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK28XhvFyksLw%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Cartier GE, Yoshikami D, Gray WR, Luo S, Olivera BM, McIntosh JM. A new α-conotoxin which targets α3β2 nicotinic acetylcholine receptors.<Emphasis Type="Italic">J Biol Chem</Emphasis>. 1996;271:7522–7528.</BibUnstructured>
              </Citation>
              <Citation ID="CR79">
                <CitationNumber>79.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>SC</Initials>
                    <FamilyName>Harvey</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JM</Initials>
                    <FamilyName>McIntosh</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>GE</Initials>
                    <FamilyName>Cartier</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>FN</Initials>
                    <FamilyName>Maddox</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>CW</Initials>
                    <FamilyName>Luetje</FamilyName>
                  </BibAuthorName>
                  <Year>1997</Year>
                  <ArticleTitle Language="En">Determinants of specificity for α-conotoxin MII on α3β2 neuronal nicotinic receptors</ArticleTitle>
                  <JournalTitle>Mol Pharmacol</JournalTitle>
                  <VolumeID>51</VolumeID>
                  <FirstPage>336</FirstPage>
                  <LastPage>342</LastPage>
                  <Occurrence Type="PID">
                    <Handle>9203640</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK2sXhtlWmsLk%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Harvey SC, McIntosh JM, Cartier GE, Maddox FN, Luetje CW. Determinants of specificity for α-conotoxin MII on α3β2 neuronal nicotinic receptors.<Emphasis Type="Italic">Mol Pharmacol</Emphasis>. 1997;51:336–342.</BibUnstructured>
              </Citation>
              <Citation ID="CR80">
                <CitationNumber>80.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>DW</Initials>
                    <FamilyName>Schulz</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>RE</Initials>
                    <FamilyName>Zigmond</FamilyName>
                  </BibAuthorName>
                  <Year>1989</Year>
                  <ArticleTitle Language="En">Neuronal bungarotoxin blocks the nicotinic stimulation of endogenous dopamine release from rat striatum</ArticleTitle>
                  <JournalTitle>Neurosci Lett</JournalTitle>
                  <VolumeID>98</VolumeID>
                  <FirstPage>310</FirstPage>
                  <LastPage>316</LastPage>
                  <Occurrence Type="PID">
                    <Handle>2566962</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaL1MXit1Gru7g%3D</Handle>
                  </Occurrence>
<Occurrence Type="DOI">
<Handle>10.1016/0304-3940(89)90420-5</Handle>
</Occurrence>
                </BibArticle>
                <BibUnstructured>Schulz DW, Zigmond RE. Neuronal bungarotoxin blocks the nicotinic stimulation of endogenous dopamine release from rat striatum.<Emphasis Type="Italic">Neurosci Lett</Emphasis>. 1989;98:310–316.</BibUnstructured>
              </Citation>
              <Citation ID="CR81">
                <CitationNumber>81.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>MR</Initials>
                    <FamilyName>Picciotto</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Zoli</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>R</Initials>
                    <FamilyName>Rimondini</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>1998</Year>
                  <ArticleTitle Language="En">Acetylcholine receptors containing the β2 subunit are invilved in the reinforcing properties of nicotine</ArticleTitle>
                  <JournalTitle>Nature</JournalTitle>
                  <VolumeID>391</VolumeID>
                  <FirstPage>173</FirstPage>
                  <LastPage>177</LastPage>
                  <Occurrence Type="PID">
                    <Handle>9428762</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK1cXmt1WrsA%3D%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Picciotto MR, Zoli M, Rimondini R, et al. Acetylcholine receptors containing the β2 subunit are invilved in the reinforcing properties of nicotine.<Emphasis Type="Italic">Nature</Emphasis>. 1998;391:173–177.</BibUnstructured>
              </Citation>
              <Citation ID="CR82">
                <CitationNumber>82.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>P</Initials>
                    <FamilyName>Whiteaker</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>MJ</Initials>
                    <FamilyName>Marks</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>SR</Initials>
                    <FamilyName>Grady</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2000</Year>
                  <ArticleTitle Language="En">Pharmacological and null mutation approaches reveal nicotinic receptor diversity</ArticleTitle>
                  <JournalTitle>Eur J Pharmacol</JournalTitle>
                  <VolumeID>393</VolumeID>
                  <FirstPage>123</FirstPage>
                  <LastPage>135</LastPage>
                  <Occurrence Type="PID">
                    <Handle>10771005</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3cXisFKjsr4%3D</Handle>
                  </Occurrence>
<Occurrence Type="DOI">
<Handle>10.1016/S0014-2999(00)00052-2</Handle>
</Occurrence>
                </BibArticle>
                <BibUnstructured>Whiteaker P, Marks MJ, Grady SR, et al. Pharmacological and null mutation approaches reveal nicotinic receptor diversity.<Emphasis Type="Italic">Eur J Pharmacol</Emphasis>. 2000;393:123–135.</BibUnstructured>
              </Citation>
              <Citation ID="CR83">
                <CitationNumber>83.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>SR</Initials>
                    <FamilyName>Grady</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>KL</Initials>
                    <FamilyName>Murphy</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J</Initials>
                    <FamilyName>Cao</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>MJ</Initials>
                    <FamilyName>Marks</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JM</Initials>
                    <FamilyName>McIntosh</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>AC</Initials>
                    <FamilyName>Collins</FamilyName>
                  </BibAuthorName>
                  <Year>2002</Year>
                  <ArticleTitle Language="En">Characterization of nicotinic agonist-induced [<Superscript>3</Superscript>H]dopamine release from synaptosomes prepared from four mouse brain regions</ArticleTitle>
                  <JournalTitle>J Pharmacol Exp Ther</JournalTitle>
                  <VolumeID>301</VolumeID>
                  <FirstPage>651</FirstPage>
                  <LastPage>660</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11961070</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD38XjtlKisrc%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Grady SR, Murphy KL, Cao J, Marks MJ, McIntosh JM, Collins AC. Characterization of nicotinic agonist-induced [<Superscript>3</Superscript>H]dopamine release from synaptosomes prepared from four mouse brain regions.<Emphasis Type="Italic">J Pharmacol Exp Ther</Emphasis>. 2002;301:651–660.</BibUnstructured>
              </Citation>
              <Citation ID="CR84">
                <CitationNumber>84.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>N</Initials>
                    <FamilyName>Champtiaux</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>ZY</Initials>
                    <FamilyName>Han</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Bessis</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2002</Year>
                  <ArticleTitle Language="En">Distribution and pharmacology of alpha 6-containing nicotinic acetylcholine receptors analyzed with mutant mice</ArticleTitle>
                  <JournalTitle>J Neurosci</JournalTitle>
                  <VolumeID>22</VolumeID>
                  <FirstPage>1208</FirstPage>
                  <LastPage>1217</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11850448</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD38XhsFeksr4%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Champtiaux N, Han ZY, Bessis A, et al. Distribution and pharmacology of alpha 6-containing nicotinic acetylcholine receptors analyzed with mutant mice.<Emphasis Type="Italic">J Neurosci</Emphasis>. 2002;22:1208–1217.</BibUnstructured>
              </Citation>
              <Citation ID="CR85">
                <CitationNumber>85.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>N</Initials>
                    <FamilyName>Champtiaux</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>C</Initials>
                    <FamilyName>Gotti</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Cordero-Erausquin</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2003</Year>
                  <ArticleTitle Language="En">Subunit composition of functional nicotinic receptors in dopaminergic neurons investigated with knock-out mice</ArticleTitle>
                  <JournalTitle>J Neurosci</JournalTitle>
                  <VolumeID>23</VolumeID>
                  <FirstPage>7820</FirstPage>
                  <LastPage>7829</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12944511</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3sXmvFGhtbc%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Champtiaux N, Gotti C, Cordero-Erausquin M, et al. Subunit composition of functional nicotinic receptors in dopaminergic neurons investigated with knock-out mice.<Emphasis Type="Italic">J Neurosci</Emphasis>. 2003;23:7820–7829.</BibUnstructured>
              </Citation>
              <Citation ID="CR86">
                <CitationNumber>86.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>P</Initials>
                    <FamilyName>Whiteaker</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>CG</Initials>
                    <FamilyName>Peterson</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>W</Initials>
                    <FamilyName>Xu</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2002</Year>
                  <ArticleTitle Language="En">The role of the α3 subunit in neuronal nicotinic biding populations</ArticleTitle>
                  <JournalTitle>J Neurosci</JournalTitle>
                  <VolumeID>22</VolumeID>
                  <FirstPage>2522</FirstPage>
                  <LastPage>2529</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11923417</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD38XisF2gurg%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Whiteaker P, Peterson CG, Xu W, et al. The role of the α3 subunit in neuronal nicotinic biding populations.<Emphasis Type="Italic">J Neurosci</Emphasis>. 2002;22:2522–2529.</BibUnstructured>
              </Citation>
              <Citation ID="CR87">
                <CitationNumber>87.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>JM</Initials>
                    <FamilyName>McIntosh</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>L</Initials>
                    <FamilyName>Azam</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Staheli</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2004</Year>
                  <ArticleTitle Language="En">Analogs of α-conotoxin MII are selective for α6-containing nicotinic acetylcholine receptors</ArticleTitle>
                  <JournalTitle>Mol Pharmacol</JournalTitle>
                  <VolumeID>65</VolumeID>
                  <FirstPage>944</FirstPage>
                  <LastPage>952</LastPage>
                  <Occurrence Type="PID">
                    <Handle>15044624</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2cXivFaltLk%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>McIntosh JM, Azam L, Staheli S, et al. Analogs of α-conotoxin MII are selective for α6-containing nicotinic acetylcholine receptors.<Emphasis Type="Italic">Mol Pharmacol</Emphasis>. 2004;65:944–952.</BibUnstructured>
              </Citation>
              <Citation ID="CR88">
                <CitationNumber>88.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>N</Initials>
                    <FamilyName>Novere</FamilyName>
                    <Particle>Le</Particle>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Zoli</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JP</Initials>
                    <FamilyName>Changeux</FamilyName>
                  </BibAuthorName>
                  <Year>1996</Year>
                  <ArticleTitle Language="En">Neuronal nicotine receptor α6 subunit mRNA is selectively concentrated in catecholaminergic nuclei of the rat brain</ArticleTitle>
                  <JournalTitle>Eur J Neurosci</JournalTitle>
                  <VolumeID>8</VolumeID>
                  <FirstPage>2428</FirstPage>
                  <LastPage>2439</LastPage>
                  <Occurrence Type="PID">
                    <Handle>8950106</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Le Novere N, Zoli M, Changeux JP. Neuronal nicotine receptor α6 subunit mRNA is selectively concentrated in catecholaminergic nuclei of the rat brain.<Emphasis Type="Italic">Eur J Neurosci</Emphasis>. 1996;8:2428–2439.</BibUnstructured>
              </Citation>
              <Citation ID="CR89">
                <CitationNumber>89.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Zoli</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Moretti</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Zanardi</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JM</Initials>
                    <FamilyName>McIntosh</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>F</Initials>
                    <FamilyName>Clementi</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>C</Initials>
                    <FamilyName>Gotti</FamilyName>
                  </BibAuthorName>
                  <Year>2002</Year>
                  <ArticleTitle Language="En">Identification of the nicotinic receptor subtypes expressed on dopaminergic terminals in the rat striatum</ArticleTitle>
                  <JournalTitle>J Neurosci</JournalTitle>
                  <VolumeID>22</VolumeID>
                  <FirstPage>8785</FirstPage>
                  <LastPage>8789</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12388584</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD38XosV2jurw%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Zoli M, Moretti M, Zanardi A, McIntosh JM, Clementi F, Gotti C. Identification of the nicotinic receptor subtypes expressed on dopaminergic terminals in the rat striatum.<Emphasis Type="Italic">J Neurosci</Emphasis>. 2002;22:8785–8789.</BibUnstructured>
              </Citation>
              <Citation ID="CR90">
                <CitationNumber>90.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>C</Initials>
                    <FamilyName>Cui</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>TK</Initials>
                    <FamilyName>Booker</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>RS</Initials>
                    <FamilyName>Allen</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2003</Year>
                  <ArticleTitle Language="En">The β3 nicotinic receptor subunit: a component of α-conotoxin MII-binding nicotinic acetylcholine receptors that modulate dopamine release and related behaviors</ArticleTitle>
                  <JournalTitle>J Neurosci</JournalTitle>
                  <VolumeID>23</VolumeID>
                  <FirstPage>11045</FirstPage>
                  <LastPage>11053</LastPage>
                  <Occurrence Type="PID">
                    <Handle>14657161</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3sXpvV2gtL8%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Cui C, Booker TK, Allen RS, et al. The β3 nicotinic receptor subunit: a component of α-conotoxin MII-binding nicotinic acetylcholine receptors that modulate dopamine release and related behaviors.<Emphasis Type="Italic">J Neurosci</Emphasis>. 2003;23:11045–11053.</BibUnstructured>
              </Citation>
              <Citation ID="CR91">
                <CitationNumber>91.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>FM</Initials>
                    <FamilyName>Goldner</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>KT</Initials>
                    <FamilyName>Dineley</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JW</Initials>
                    <FamilyName>Patrick</FamilyName>
                  </BibAuthorName>
                  <Year>1997</Year>
                  <ArticleTitle Language="En">Immunohistochemical localization of the nicotinic acetylcholine receptor subunit α6 to dopaminergic neurons in the substantia nigra and ventral tegmental area</ArticleTitle>
                  <JournalTitle>Neuroreport</JournalTitle>
                  <VolumeID>8</VolumeID>
                  <FirstPage>2739</FirstPage>
                  <LastPage>2742</LastPage>
                  <Occurrence Type="PID">
                    <Handle>9295110</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK2sXmt1WltLs%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1097/00001756-199708180-00019</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Goldner FM, Dineley KT, Patrick JW. Immunohistochemical localization of the nicotinic acetylcholine receptor subunit α6 to dopaminergic neurons in the substantia nigra and ventral tegmental area.<Emphasis Type="Italic">Neuroreport</Emphasis>. 1997;8:2739–2742.</BibUnstructured>
              </Citation>
              <Citation ID="CR92">
                <CitationNumber>92.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>E</Initials>
                    <FamilyName>Charpantier</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>P</Initials>
                    <FamilyName>Barneoud</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>P</Initials>
                    <FamilyName>Moser</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>F</Initials>
                    <FamilyName>Besnard</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>F</Initials>
                    <FamilyName>Sgard</FamilyName>
                  </BibAuthorName>
                  <Year>1998</Year>
                  <ArticleTitle Language="En">Nicotinic acetylcholine subunit mRNA expression in dopaminergic neurons of the rat substantia nigra and ventral tegmental area</ArticleTitle>
                  <JournalTitle>Neuroreport</JournalTitle>
                  <VolumeID>9</VolumeID>
                  <FirstPage>3097</FirstPage>
                  <LastPage>3101</LastPage>
                  <Occurrence Type="PID">
                    <Handle>9804323</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK1cXntFOju7s%3D</Handle>
                  </Occurrence>
<Occurrence Type="DOI">
<Handle>10.1097/00001756-199809140-00033</Handle>
</Occurrence>
                </BibArticle>
                <BibUnstructured>Charpantier E, Barneoud P, Moser P, Besnard F, Sgard F. Nicotinic acetylcholine subunit mRNA expression in dopaminergic neurons of the rat substantia nigra and ventral tegmental area.<Emphasis Type="Italic">Neuroreport</Emphasis>. 1998;9:3097–3101.</BibUnstructured>
              </Citation>
              <Citation ID="CR93">
                <CitationNumber>93.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>O</Initials>
                    <FamilyName>Salminen</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>KL</Initials>
                    <FamilyName>Murphy</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JM</Initials>
                    <FamilyName>McIntosh</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2004</Year>
                  <ArticleTitle Language="En">Subunit composition and pharmacology of two classes of striatal presynaptic nicotinic acetylcholine receptors mediating dopamine release in mice</ArticleTitle>
                  <JournalTitle>Mol Pharmacol</JournalTitle>
                  <VolumeID>65</VolumeID>
                  <FirstPage>1526</FirstPage>
                  <LastPage>1535</LastPage>
                  <Occurrence Type="PID">
                    <Handle>15155845</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2cXksFagt7Y%3D</Handle>
                  </Occurrence>
<Occurrence Type="DOI">
<Handle>10.1124/mol.65.6.1526</Handle>
</Occurrence>
                </BibArticle>
                <BibUnstructured>Salminen O, Murphy KL, McIntosh JM, et al. Subunit composition and pharmacology of two classes of striatal presynaptic nicotinic acetylcholine receptors mediating dopamine release in mice.<Emphasis Type="Italic">Mol Pharmacol</Emphasis>. 2004;65:1526–1535.</BibUnstructured>
              </Citation>
              <Citation ID="CR94">
                <CitationNumber>94.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>R</Initials>
                    <FamilyName>Zwart</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>HP</Initials>
                    <FamilyName>Vijverberg</FamilyName>
                  </BibAuthorName>
                  <Year>1998</Year>
                  <ArticleTitle Language="En">Four pharmacologically distinct subtypes of alpha4beta2 nicotinic acetylcholine receptor expressed in<Emphasis Type="Italic">Xenopus laevis</Emphasis> oocytes</ArticleTitle>
                  <JournalTitle>Mol Pharmacol</JournalTitle>
                  <VolumeID>54</VolumeID>
                  <FirstPage>1124</FirstPage>
                  <LastPage>1131</LastPage>
                  <Occurrence Type="PID">
                    <Handle>9855643</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK1MXptVai</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Zwart R, Vijverberg HP. Four pharmacologically distinct subtypes of alpha4beta2 nicotinic acetylcholine receptor expressed in<Emphasis Type="Italic">Xenopus laevis</Emphasis> oocytes.<Emphasis Type="Italic">Mol Pharmacol</Emphasis>. 1998;54:1124–1131.</BibUnstructured>
              </Citation>
              <Citation ID="CR95">
                <CitationNumber>95.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>GY</Initials>
                    <FamilyName>Lopez-Hernandez</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J</Initials>
                    <FamilyName>Sanchez-Padilla</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Ortiz-Acevedo</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2004</Year>
                  <ArticleTitle Language="En">Nicotine-induced upregulation and desensitization of α 4β2 neuronal nicotinic receptors depend on subunit ratio</ArticleTitle>
                  <JournalTitle>J Biol Chem</JournalTitle>
                  <VolumeID>279</VolumeID>
                  <FirstPage>38007</FirstPage>
                  <LastPage>38015</LastPage>
                  <Occurrence Type="PID">
                    <Handle>15247303</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2cXntFSnt70%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Lopez-Hernandez GY, Sanchez-Padilla J, Ortiz-Acevedo A, et al. Nicotine-induced upregulation and desensitization of α 4β2 neuronal nicotinic receptors depend on subunit ratio.<Emphasis Type="Italic">J Biol Chem</Emphasis>. 2004;279:38007–38015.</BibUnstructured>
              </Citation>
              <Citation ID="CR96">
                <CitationNumber>96.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>ME</Initials>
                    <FamilyName>Nelson</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Kuryatov</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>CH</Initials>
                    <FamilyName>Choi</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>Y</Initials>
                    <FamilyName>Zhou</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J</Initials>
                    <FamilyName>Lindstrom</FamilyName>
                  </BibAuthorName>
                  <Year>2003</Year>
                  <ArticleTitle Language="En">Alternate stoichiometries of alpha4beta2 nicotinic acetylcholine receptors</ArticleTitle>
                  <JournalTitle>Mol Pharmacol</JournalTitle>
                  <VolumeID>63</VolumeID>
                  <FirstPage>332</FirstPage>
                  <LastPage>341</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12527804</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3sXnvV2htA%3D%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Nelson ME, Kuryatov A, Choi CH, Zhou Y, Lindstrom J. Alternate stoichiometries of alpha4beta2 nicotinic acetylcholine receptors.<Emphasis Type="Italic">Mol Pharmacol</Emphasis>. 2003;63:332–341.</BibUnstructured>
              </Citation>
              <Citation ID="CR97">
                <CitationNumber>97.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>PA</Initials>
                    <FamilyName>Crooks</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Ravard</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>LH</Initials>
                    <FamilyName>Wilkins</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>LH</Initials>
                    <FamilyName>Teng</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>ST</Initials>
                    <FamilyName>Buxton</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>LP</Initials>
                    <FamilyName>Dwoskin</FamilyName>
                  </BibAuthorName>
                  <Year>1995</Year>
                  <ArticleTitle Language="En">Inhibition of nicotine-evoked [<Superscript>3</Superscript>H]dopamine release by pyridino<Emphasis Type="Italic">N</Emphasis>-substituted nicotine analogues: a new class of nicotinic antagonist</ArticleTitle>
                  <JournalTitle>Drug Dev Res</JournalTitle>
                  <VolumeID>36</VolumeID>
                  <FirstPage>91</FirstPage>
                  <LastPage>102</LastPage>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK2MXptVyms7o%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Crooks PA, Ravard A, Wilkins LH, Teng LH, Buxton ST, Dwoskin LP. Inhibition of nicotine-evoked [<Superscript>3</Superscript>H]dopamine release by pyridino<Emphasis Type="Italic">N</Emphasis>-substituted nicotine analogues: a new class of nicotinic antagonist.<Emphasis Type="Italic">Drug Dev Res</Emphasis>. 1995;36:91–102.</BibUnstructured>
              </Citation>
              <Citation ID="CR98">
                <CitationNumber>98.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>LP</Initials>
                    <FamilyName>Dwoskin</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>R</Initials>
                    <FamilyName>Xu</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JT</Initials>
                    <FamilyName>Ayers</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>PA</Initials>
                    <FamilyName>Crooks</FamilyName>
                  </BibAuthorName>
                  <Year>2000</Year>
                  <ArticleTitle Language="En">Recent developments in neuronal nicotinic acetylcholine receptor antagonists</ArticleTitle>
                  <JournalTitle>Exp Opin Ther Pat</JournalTitle>
                  <VolumeID>10</VolumeID>
                  <FirstPage>1561</FirstPage>
                  <LastPage>1581</LastPage>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3cXnt1antrk%3D</Handle>
                  </Occurrence>
<Occurrence Type="DOI">
<Handle>10.1517/13543776.10.10.1561</Handle>
</Occurrence>
                </BibArticle>
                <BibUnstructured>Dwoskin LP, Xu R, Ayers JT, Crooks PA. Recent developments in neuronal nicotinic acetylcholine receptor antagonists.<Emphasis Type="Italic">Exp Opin Ther Pat</Emphasis>. 2000;10:1561–1581.</BibUnstructured>
              </Citation>
              <Citation ID="CR99">
                <CitationNumber>99.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>LP</Initials>
                    <FamilyName>Dwoskin</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>PA</Initials>
                    <FamilyName>Crooks</FamilyName>
                  </BibAuthorName>
                  <Year>2001</Year>
                  <ArticleTitle Language="En">Competitive neuronal nicotinic receptor antagonists: a new direction for drug discovery</ArticleTitle>
                  <JournalTitle>J Pharmacol Exp Ther</JournalTitle>
                  <VolumeID>298</VolumeID>
                  <FirstPage>395</FirstPage>
                  <LastPage>402</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11454899</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3MXlsVKqsrg%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Dwoskin LP, Crooks PA. Competitive neuronal nicotinic receptor antagonists: a new direction for drug discovery.<Emphasis Type="Italic">J Pharmacol Exp Ther</Emphasis>. 2001;298:395–402.</BibUnstructured>
              </Citation>
              <Citation ID="CR100">
                <CitationNumber>100.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>LH</Initials>
                    <FamilyName>Wilkins</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>VP</Initials>
                    <FamilyName>Grinevich</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JT</Initials>
                    <FamilyName>Ayers</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>PA</Initials>
                    <FamilyName>Crooks</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>LP</Initials>
                    <FamilyName>Dwoskin</FamilyName>
                  </BibAuthorName>
                  <Year>2003</Year>
                  <ArticleTitle Language="En">
                    <Emphasis Type="Italic">N-n</Emphasis>-Alkylnicotinium analogs, a novel class of nicotinic receptor antagonists: interaction with α4β2<Superscript>*</Superscript> and α7<Superscript>*</Superscript> neuronal nicotinic receptors</ArticleTitle>
                  <JournalTitle>J Pharmacol Exp Ther</JournalTitle>
                  <VolumeID>304</VolumeID>
                  <FirstPage>400</FirstPage>
                  <LastPage>410</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12490617</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3sXht1SntA%3D%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Wilkins LH, Grinevich VP, Ayers JT, Crooks PA, Dwoskin LP.<Emphasis Type="Italic">N-n</Emphasis>-Alkylnicotinium analogs, a novel class of nicotinic receptor antagonists: interaction with α4β2<Superscript>*</Superscript> and α7<Superscript>*</Superscript> neuronal nicotinic receptors.<Emphasis Type="Italic">J Pharmacol Exp Ther</Emphasis>. 2003;304:400–410.</BibUnstructured>
              </Citation>
              <Citation ID="CR101">
                <CitationNumber>101.</CitationNumber>
                <BibUnstructured>Crooks PA, Xu R, Sumithran SP, Deaciue AG, Dwoskin LP. NONI and NDNI analogs: structural modification of the<Emphasis Type="Italic">N-n</Emphasis>-alkyl moiety and the effect on neuronal nicotinic receptor activity.<Emphasis Type="Italic">Bioorg Med Chem</Emphasis> 2005.</BibUnstructured>
              </Citation>
              <Citation ID="CR102">
                <CitationNumber>102.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>MM</Initials>
                    <FamilyName>Bradford</FamilyName>
                  </BibAuthorName>
                  <Year>1976</Year>
                  <ArticleTitle Language="En">A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding</ArticleTitle>
                  <JournalTitle>Anal Biochem</JournalTitle>
                  <VolumeID>72</VolumeID>
                  <FirstPage>248</FirstPage>
                  <LastPage>254</LastPage>
                  <Occurrence Type="PID">
                    <Handle>942051</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaE28XksVehtrY%3D</Handle>
                  </Occurrence>
<Occurrence Type="DOI">
<Handle>10.1016/0003-2697(76)90527-3</Handle>
</Occurrence>
                </BibArticle>
                <BibUnstructured>Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.<Emphasis Type="Italic">Anal Biochem</Emphasis>. 1976;72:248–254.</BibUnstructured>
              </Citation>
              <Citation ID="CR103">
                <CitationNumber>103.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>DK</Initials>
                    <FamilyName>Miller</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>PA</Initials>
                    <FamilyName>Crooks</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>LP</Initials>
                    <FamilyName>Dwoskin</FamilyName>
                  </BibAuthorName>
                  <Year>2000</Year>
                  <ArticleTitle Language="En">Lobeline inhibits nicotine-evoked [<Superscript>3</Superscript>H]dopamine overflow from rat striatal slices and nicotine-evoked<Superscript>86</Superscript>Rb<Superscript>+</Superscript> efflux from thalamic synaptosomes</ArticleTitle>
                  <JournalTitle>Neuropharmacology</JournalTitle>
                  <VolumeID>39</VolumeID>
                  <FirstPage>2654</FirstPage>
                  <LastPage>2662</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11044735</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3cXntlGqsLk%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Miller DK, Crooks PA, Dwoskin LP. Lobeline inhibits nicotine-evoked [<Superscript>3</Superscript>H]dopamine overflow from rat striatal slices and nicotine-evoked<Superscript>86</Superscript>Rb<Superscript>+</Superscript> efflux from thalamic synaptosomes.<Emphasis Type="Italic">Neuropharmacology</Emphasis>. 2000;39:2654–2662.</BibUnstructured>
              </Citation>
              <Citation ID="CR104">
                <CitationNumber>104.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>J</Initials>
                    <FamilyName>Zhu</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>PA</Initials>
                    <FamilyName>Crooks</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JT</Initials>
                    <FamilyName>Ayers</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>SP</Initials>
                    <FamilyName>Sumithran</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>LP</Initials>
                    <FamilyName>Dwoskin</FamilyName>
                  </BibAuthorName>
                  <Year>2003</Year>
                  <ArticleTitle Language="En">
                    <Emphasis Type="Italic">N-n</Emphasis>-Alkylnicotinium and<Emphasis Type="Italic">N-n</Emphasis>-alkylpyridinium analogs inhibit the dopamine transporter: Selectivity as nicotinic receptor antagonists</ArticleTitle>
                  <JournalTitle>Drug Dev Res</JournalTitle>
                  <VolumeID>60</VolumeID>
                  <FirstPage>270</FirstPage>
                  <LastPage>284</LastPage>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3sXpsFClu7c%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Zhu J, Crooks PA, Ayers JT, Sumithran SP, Dwoskin LP.<Emphasis Type="Italic">N-n</Emphasis>-Alkylnicotinium and<Emphasis Type="Italic">N-n</Emphasis>-alkylpyridinium analogs inhibit the dopamine transporter: Selectivity as nicotinic receptor antagonists.<Emphasis Type="Italic">Drug Dev Res</Emphasis>. 2003;60:270–284.</BibUnstructured>
              </Citation>
              <Citation ID="CR105">
                <CitationNumber>105.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>Y</Initials>
                    <FamilyName>Cheng</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>WH</Initials>
                    <FamilyName>Prusoff</FamilyName>
                  </BibAuthorName>
                  <Year>1973</Year>
                  <ArticleTitle Language="En">Relationship between the inhibition constant (Ki) and the concentration of inhibitor which causes 50 percent inhibition (I<Subscript>50</Subscript>) of an enzymatic reaction</ArticleTitle>
                  <JournalTitle>Biochem Pharmacol</JournalTitle>
                  <VolumeID>22</VolumeID>
                  <FirstPage>3099</FirstPage>
                  <LastPage>3108</LastPage>
                  <Occurrence Type="PID">
                    <Handle>4202581</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaE2cXhtVGgs7c%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Cheng Y, Prusoff WH. Relationship between the inhibition constant (Ki) and the concentration of inhibitor which causes 50 percent inhibition (I<Subscript>50</Subscript>) of an enzymatic reaction.<Emphasis Type="Italic">Biochem Pharmacol</Emphasis>. 1973;22:3099–3108.</BibUnstructured>
              </Citation>
              <Citation ID="CR106">
                <CitationNumber>106.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>DS</Initials>
                    <FamilyName>McGehee</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>MJ</Initials>
                    <FamilyName>Heath</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Gelber</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>P</Initials>
                    <FamilyName>Devay</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>LW</Initials>
                    <FamilyName>Role</FamilyName>
                  </BibAuthorName>
                  <Year>1995</Year>
                  <ArticleTitle Language="En">Nicotinic enhancement of fast excitatory synaptic transmission in CNS by presynaptic receptors</ArticleTitle>
                  <JournalTitle>Science</JournalTitle>
                  <VolumeID>269</VolumeID>
                  <FirstPage>1692</FirstPage>
                  <LastPage>1696</LastPage>
                  <Occurrence Type="PID">
                    <Handle>7569895</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK2MXot1aisbY%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>McGehee DS, Heath MJ, Gelber S, Devay P, Role LW. Nicotinic enhancement of fast excitatory synaptic transmission in CNS by presynaptic receptors.<Emphasis Type="Italic">Science</Emphasis>. 1995;269:1692–1696.</BibUnstructured>
              </Citation>
              <Citation ID="CR107">
                <CitationNumber>107.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>SA</Initials>
                    <FamilyName>Kaiser</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Wonnacott</FamilyName>
                  </BibAuthorName>
                  <Year>2000</Year>
                  <ArticleTitle Language="En">α-Bungarotoxin-sensitive nicotinic receptors indirectly modulate [<Superscript>3</Superscript>H]dopamine release in rat striatal slices via glutamate release</ArticleTitle>
                  <JournalTitle>Mol Pharmacol</JournalTitle>
                  <VolumeID>58</VolumeID>
                  <FirstPage>312</FirstPage>
                  <LastPage>318</LastPage>
                  <Occurrence Type="PID">
                    <Handle>10908298</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3cXlsVymsL8%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Kaiser SA, Wonnacott S. α-Bungarotoxin-sensitive nicotinic receptors indirectly modulate [<Superscript>3</Superscript>H]dopamine release in rat striatal slices via glutamate release.<Emphasis Type="Italic">Mol Pharmacol</Emphasis>. 2000;58:312–318.</BibUnstructured>
              </Citation>
            </Bibliography>
          </ArticleBackmatter>
        </Article>
      </Issue>
    </Volume>
  </Journal>
</Publisher>
